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Hypochlorous acid (HOCl) mediated oxidative damage to tissue proteins has been 
implicated in the pathogenesis of various inflammatory diseases. These include 
atherosclerosis, respiratory distress, ischemia-reperfusion injury and liver cirrhosis. Liver 
cirrhosis is often preceded by overt signs of hepatitis, including parenchymal cell 
inflammation and infiltration of polymorphonuclear (PMN) leukocytes. These activated 
PMNs then release both reactive oxygen species and reactive halogen species, including 
hypochlorous acid (HOCl) which has been shown to participate in the oxidation and 
chlorination of proteins. HOCl is also known to deplete intracellular ATP, reduce 
glutathione (GSH) and cause necrotic/apoptotic cell death. Thus, it would be of interest to 
identify protein targets in liver cells that are affected by this oxidant to enable us to 
understand the underlying basis of chlorination, oxidation and its effect on molecular 
functions. In our study using a 2-dimensional difference gel electrophoresis (2D-DIGE) 
approach to profile the differentially expressed proteins of HOCl treated human hepatoma 
HepG2 cell line, various cytosolic and mitochondrial proteins with antioxidant and 
metabolic activities, were identified to be upregulated and downregulated respectively. 
Western blotting using anti-DNP antibodies to detect carbonylated proteins additionally 
revealed changes in the oxidation status of several nuclear and mitochondrial proteins. 
With the use of mass spectrometry, we managed to further locate and identify potential 
chlorinated proteins (via tyrosine residues). These were namely hnRNPK and lamin A/C, 
which both reside in the nucleus. The post-translational modifications to these protein 
candidates might contribute to protein dysfunction, leading to possible functional 
impairment of the cells and induction of apoptotic cell death signals upon HOCl exposure. 
 viii
The results of this study serve as a useful and significant step towards the understanding 
of the HOCl mechanisms on cells. 
 ix
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1.       INTRODUCTION 
 
1.1 Reactive Oxygen Species (ROS) 
Reactive Oxygen Species (ROS) is a collective term that includes oxygen 
radicals such as superoxide anion (O2·-), hydroxyl radical (OH·) and peroxyl radical 
(RO2·), as well as some non-radical derivatives of oxygen (O2) such as hydrogen 
peroxide (H2O2), ozone (O3) and hypochlorous acid (HOCl). ROS are generally very 
small molecules and yet are highly reactive due to the presence of unpaired valence 

















A) Oxygen radicals 




( HOCl ) 
oxygen 
( O2 ) 
superoxide anion  
(   O2- )
hydroxyl radical
( OH )
hydrogen peroxide  
( H2O2 ) 
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ROS are formed by three different mechanisms: 
1) via the interaction of ionizing radiation with biological molecules.  
2) as an unavoidable, natural byproduct of cellular respiration. Some electrons 
passing "down" the respiratory chain leak away from the main path (especially 
as they pass through ubiquinone) and go directly to reduce oxygen molecules to 
the superoxide anion. 
3) synthesized by dedicated enzymes such as NADPH oxidase and 
myeloperoxidase,  in phagocytic cells like neutrophils and macrophages. 
ROS are essential as they have important functions to perform in the cell. For 
example, the cells of the thyroid gland must make hydrogen peroxide (H2O2) in order to 
attach iodine atoms to thyroglobulin in the synthesis of thyroxine. Macrophages and 
neutrophils must also generate ROS in order to kill some types of bacteria that they 
engulf by phagocytosis via the conversion of O2
·- into H2O2 by superoxide dismutase 
(SOD), which kills off the engulfed bacteria. It also has positive effects such as the 
induction of host defense genes and mobilization of ion transport systems. In particular, 
platelets involved in wound repair and blood homeostasis also release ROS to recruit 
additional platelets to sites of injury.  
During normal metabolism, cells are able to defend themselves against ROS 
damage through the use of the naturally occurring enzymatic and non-enzymatic 
systems. The former includes antioxidant enzymes such as superoxide dismutases 
(SODs), catalases, peroxiredoxins and glutathione peroxidases, and the latter comprise 
of small molecules such as alpha-tocopherol (vitamin E), uric acid and vitamin C. The 
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balance between physiological functions and damaging actions of ROS is determined 
by the relative rates of formation and removal of ROS. While ROS can play important 
physiological functions in cells, they can also cause extensive cellular damage via 
oxidative stress especially when there are imbalances between the generation of ROS 
and the antioxidant defense capacities of the body. In these physiological states, ROS 
are removed rapidly before they exceed the antioxidant capacity that can cause cell 
dysfunction affecting the major cellular components such as lipids, proteins, 
carbohydrates and cellular macromolecules (DNA & RNA), and ultimately cell death 
via apoptosis or necrosis. 
 
1.2 ROS and human diseases 
 
Protein oxidation has been implicated in a wide range of neurodegenerative 
diseases like Freidreichs ataxia (Puccio et al., 2002; Schon et al., 2003; Pandolfo, 1999), 
Parkinson’s disease (Betarbet et al., 2002; Sherer et al., 2001), Alzheimer’s disease 
(Smith et al., 1991), amyotrophic lateral sclerosis (ALS) (Beal, 2001; Beal, 2002; 
Valentine, 2002) and transmissible spongiform encephalopathies (TSE) (Milhavet et al., 
2000; Milhavet et al., 2002), as well as in normal aging (Smith et al., 1992; Carney et 
al., 1994). It has also been found to be involved in several respiratory and inflammatory 
diseases such as acute (adult) respiratory distress syndrome (ARDS) (Lamb et al., 1999; 
Lang et al., 2002), asthma (Dworski, 2000; Rahman et al., 1996), chronic obstructive 
pulmonary diseases (COPD) (Rahman et al., 1996; Comhair et al., 2002; Langen et al., 
2003; Morrison et al., 1999), atherosclerosis (Harrison et al., 2003) and rheumatoid 
arthritis (Witztum et al., 1991; Berliner et al., 1996).  
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Studies have proven that oxidative and/or nitrosative stresses have a major role 
in the pathogenesis of these diseases. These are substantiated by evidences of ROS / 
RNS formation, protein oxidation, and lipid peroxidation, and other markers of 
oxidative damage in tissues and/or sites of inflammation (Dalle-Donne et al., 2005). 
 
1.3 Formation of ROS 
 
1.3.1 ROS as a natural byproduct of cellular respiration in non-phagocytic cells 
 
Most cellular ROS in non-phagocytic cells are formed as byproducts of cellular 
respiration via the endogenous mitochondrial electron transport chain. The ROS free 
radicals and their reactive non-radical derivatives such as H2O2, are produced in all cells 
at very low physiological concentrations during oxidative phosphorylation (Mikkelsen 
et al., 2003). This tight control is established by a balance of generation and 
neutralization processes. Disruption of this by imbalance of oxidants or anti-oxidants, 
will trigger redox signaling and induce cellular protective mechanisms to re-establish 
the initial redox / free radical balance.  
Under normal physiological condition, superoxide anion (O2
·-) formed by the 
mitochondrial electron flow is rapidly converted within the cells into hydrogen peroxide 
(H2O2) and oxygen (O2) by superoxide dismutases (SODs). H2O2 can react with reduced 
transition metals via the Fenton reaction to produce the highly reactive hydroxyl radical 
(OH·), which is of higher damaging effect to the cells than the former. Alternatively it 
can be harmlessly converted into water (H2O) by the enzymes catalase (CAT) and 
gluthathione peroxidase (GPX) (Dalle-Donne et al., 2005). (Figure 2) 
Introduction 6
Under certain pathological conditions, When O2
·- comes into contact with nitric 
oxide radicals (NO·), a source of oxidative/nitrosative stress, NO· can compete with 
enzymes for the removal of O2
·- by forming peroxynitrite (ONOO-), and other reactive 





















































1.3.2 ROS in phagocytic cells – formation of hypochlorous acid (HOCl) 
 
During early stages of acute inflammation, oxidants are generated by stimulated 
phagocytes such as neutrophils and monocytes. The pathways begin with the activation 
of a membrane-associated reduced nicotinamide dinucleotide phosphate (NADPH) 
oxidase that produces superoxide anion (O2
·-) (Hurst, 1989; Klebanoff, 1980). O2
·- is 
then spontaneously or enzymatically dismutated to form hydrogen peroxide (H2O2). 
Myeloperoxidase (MPO), a heme protein released by the stimulated phagocytic cells 
then uses the oxidizing potential of H2O2 to convert plasma concentrations of chloride 
ion (Cl
-
) into a reactive chlorine species (RCS), hypochlorous acid (HOCl) 
(Winterbourn, 2002) (Figure 3). HOCl, the major strong oxidant generated by activated 











Figure 3: Reactive oxygen species in activated phagocytic cells  
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Myeloperoxidase (MPO) is one of the most abundant proteins in phagocytes, 
representing approximately 5% and 1% of total proteins in neutrophils and monocytes 
respectively (Nauseef, 1988). Studies have suggested that it is also present in human 
macrophages in vivo (Daugherty, 1994; Brown et al., 2001). The ability of MPO to 
generate hypochlorous acid/hypochlorite (HOCl/OCl
-
) from hydrogen peroxide in the 
presence of chloride ions is a unique and defining activity for this enzyme. MPO is also 
able to form RNS with protein nitrating activity when both nitrite and H2O2 are present 
(Eiserich et al., 1998).  
Several studies have proposed that HOCl and other oxidizing intermediates 
generated by MPO also contribute to the tissue damage at sites of inflammation (Weiss, 
1989; Heinecke, 1997; Hazen et al., 1997). Thus it would be of interest to understand 
the involvement of HOCl on cellular components and inflammatory diseases. 
 
1.4 Human diseases associated with HOCl 
 
 
HOCl oxidative / chlorinative damage to tissue proteins has been implicated in 
the pathogenesis of various inflammatory diseases such as atherosclerosis (Dalle-Donne 
et al., 2005; Hazen et al., 1997; Heinecke, 1999), respiratory distress, asthma (Dworski, 
2000), ischemia-reperfusion injury (Hasegawa et al., 2005), glomerulonephritis (Malle 
et al., 2003; GrÖne et al., 2002), liver cirrhosis (Brown et al., 2001; Whiteman et al., 
2005), hepatocellular injury during endotoxemia (Gujral, Hinson and Farhood et al., 




In atherosclerosis, cholesterol-laden macrophages called foam cells are the 
cellular hallmark of early atherosclerosis lesions. Catalytically active myeloperoxidase 
is found to co-localize with these foam cells in atherosclerotic lesions (Daugherty et al., 
1994).  Isotope dilution gas chromatography / mass spectrometry (GC/MS) analysis of 
protein oxidation products in atherosclerotic tissue in vivo have found that levels of 
tyrosyl radicals and 3-chlorotyrosines (a stable biomarker of HOCl) in lesion low 
density lipoprotein (LDL) was 100 times & 30 times higher than in circulating LDL 
respectively (Leeuwenburgh et al., 1997; Hazen et al., 1997). These strongly suggest 
that MPO and its reactive intermediates such as tyrosyl radicals, reactive aldehydes and 
HOCl may play a role in rendering LDL oxidation and lesion formation in vivo in 
atherosclerosis. 
 
1.4.2 Ischemia reperfusion 
In ischemia reperfusion injury such as in liver tissue, HOCl has also been found 
to play a role in the process of neutrophil-induced tissue injury in vivo. With the use of a 
mouse model of 60 minutes of partial hepatic ischemia and 0–24 hours of reperfusion 
(Hasegawa et al., 2005), the author was able to show increasing oxidative stress induced 
liver injury throughout the reperfusion with the use of general oxidant stress biomarkers 
such as glutathione disulfide (GSSG) and malondialdehyde (MDA). At the same time, 
hepatocytes stained for HOCl-modified epitopes increased from 6-24 hours of 
reperfusion, correlating with bulk of hepatic neutrophil accumulation and extravasation 
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into the parenchyma. These show that HOCl-induced oxidative stress is involved in the 
process of neutrophil-induced tissue injury in ischemia reperfusion. 
 
1.4.3 Glomerulonephritis 
In glomerulonephritis, various experiments to detect the presence of HOCl-
modified proteins by immunostaining with specific anti-HOCl monoclonal antibodies, 
indicated that oxidative modification of the basement membrane structure by 
phagocyte-derived HOCl (MPO-H2O2-halide system) may be of importance for 
glomerular defects/dysfunction in patients (Malle et al., 2003; GrÖne et al., 2002). This 
is shown by co-localization of HOCl-modified proteins and MPO in podocytes and 
glomerular peripheral basement membranes in human membranous glomerulonephritis, 
which is not observed in human minimal change glomerulopathy. Furthermore, a 
pronounced infiltration of mononuclear cells / glomerulus in membrane-proliferative 
glomerulonephritis is in line with positive staining for HOCl-modified epitopes. 
 
1.4.4 Liver cirrhosis 
In liver cirrhosis, immunohistochemistry staining of myeloperoxidases detected 
the presence of the enzyme in sinusoidal lining cells of diseased human livers, showing 
that myeloperoxidase is present in kupffer cells, which are specialized macrophages 
located in the liver (Brown et al., 2001). Immunostaining with HOP-1, a monoclonal 
antibody raised against HOCl-modified LDL that recognizes HOCl-specific epitopes, 
and is specific to proteins modified by HOCl, was observed in close association with 
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macrophages only in diseased liver. This suggests enhancement of MPO activity during 
tissue injury. In cases of acute liver injury, HOP-1 reactivity was found to be most 
prominent in necrotic areas infiltrated by macrophages. But in chronic liver diseases 
with cirrhosis, HOP-1 reactivity showed HOCl-modified proteins to be localized to 
hepatocytes adjacent to the fibrous septa. These demonstrate that HOCl and its other 
oxidizing intermediates generated by MPO can result in tissue damage at sites of 
inflammation. 
Therefore, it would be interesting to elucidate the effects of HOCl on cells 
during inflammatory tissue injury, such as hepatocytes in liver. 
 
1.5 Biological reactions of hypochlorous acid (HOCl) 
Hypochlorous acid (HOCl) is produced by the enzyme MPO in activated 
phagocytes via the following reaction: 
 
    
HOCl is a weak acid with a pKa of approximately 7.5. At a physiological pH of 7.4, it is 
about 50 % ionized to hypochlorite (OCl
- 
), 
             
 
Besides playing an important role in bacterial killing by phagocytes, HOCl is also 
highly reactive and able to damage biomolecules both directly and by indirectly 
decomposing to form chlorine. 
H2O2 + Cl
-                             HOCl + OH
-
 MPO







HOCl in the micromolar concentration range is not toxic, but it can be converted to 
apoptosis-inducing hydroxyl radicals through the interaction with superoxide anions 
( O2
. - 
) to generate highly reactive hydroxyl radicals (OH 
. 










It could also be possible that the direct reaction of HOCl with O2
. - 
could be catalyzed by 
traces of iron ions, such that O2
. – 




(Halliwell and Gutteridge, 1999). 
HOCl is a powerful two-electron oxidizing agent that can react with many 
biological molecules. HOCl also seems able to cross membranes and cause damage to 
membrane proteins in its passage (especially to –SH groups and methionine residues), 
and to intracellular constituents when it enters the cytoplasm. HOCl can react most 
rapidly to oxidize thiols and thioethers, ascorbate, NAD(P)H and cause chlorination of 
DNA bases especially pyrimidines. HOCl has also been shown to affect the levels and 
activities of a number of cell constituents important in maintaining cellular functions, 
such as oxidation and inhibition of glyceraldehydes-3-phosphate dehydrogenase 
HOCl  +  O2
. -
                           O2  +  Cl 
-
 +  OH 
.  
   
HOCl  +  Fe
 2+
                           Fe3+  +  Cl 
-
 +  OH 
.  
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(GAPDH) (Pullar et al. 1999) and depletion of intracellular ATP (Abernathy et al., 
1995; Dallegri et al., 1988). 
 
1.5.1 Oxidized glutathione and cyclic sulfonamides 
HOCl is known to reduce intracellular GSH, an important cellular antioxidant, 
by reacting to form oxidized glutathione (GSSG) and other irreversibly oxidized 
products such as cyclic sulfonamide. Experiments to investigate the effects of sublethal 
doses of HOCl on neutrophils (Carr et al., 1997b) and endothelial cells (Pullar et al., 
2001) showed GSH loss with minimal formation of GSSG and protein mixed disulfides. 
The bulk of the GSH loss occurred as GSH products which were rapidly exported from 
the cells and detected in the extracellular medium. These include sulfonamide and other 
products yet to be identified. This suggested that HOCl generated at sites of 
inflammation has the potential of depleting the surrounding cells of their GSH by 
causing irreversible loss of intracellular GSH and compromising their antioxidant 
defenses and detoxification pathways against further oxidative stress.  
 
1.5.2 Chloramines 




RNH2 + HOCl                     RNHCl + H2O  (Reaction 1) 
 
RNHCl + HOCl                   RNCl2 + H2O   (Reaction 2) 
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It can react rapidly with nucleotides and nucleic acid bases such as NADH and the 
amino (NH) groups of pyrimidines to give chloramines. Chlorination of thymidine and 
uridine give rise to heterocyclic chloramines which are themselves reactive and able to 
act as chlorine donors, while that of cytosine results in the formation of a more stable 
end-product, 5-chlorocytosine (Prutz, 1996; Prutz, 1998).  
 HOCl can also react with amino groups of aliphatic amino acids of cellular 
proteins such as lysine and the N-terminal amines to form chloramines (Pullar et al., 
2000). Chloramines can oxidize thiols, thioethers and heme-containing proteins, thus 
extending the reactive effects of HOCl. To enhance its toxicity to cells, chloramines of 
α-amino acids can also spontaneously breakdown to aldehydes, with the release of 
ammonia and carbon dioxide (Hazen et al., 1996). Chloramines are also found to 
possibly generate radicals that may result in protein fragmentation or lipid peroxidation 
(Hawkins et al., 1999; Hazell et al., 1999). HOCl reaction with taurine (2-
aminoethanesulphonic acid), an end-product of the metabolism of sulphur-containing 
amino acids that is present at high levels in many mammalian tissues, can also result in 
the formation of taurine chloramines, which can inactivate α-antiproteinase (Halliwell 
and Gutteridge, 1999).  
 
1.5.3 Chlorohydrins 
 Addition of HOCl to unsaturated fatty acids and cholesterol has also shown that 
it can add across double bonds (C=C) to form chlorohydrins (Winterbourn et al., 1992). 
Chlorohydrins are relatively stable, except that it can undergo HCl elimination to form 
epoxides under mildly alkaline conditions. Epoxides are found to affect the G1/S 
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progression in cell cycle by inducing G1 arrest (Mlejnek et al., 1999). They can also 
induce significant decrease of intracellular level of reduced glutathione (GSH), leading 
to cell death via necrosis. 
 
1.5.4 Protein carbonyls 
HOCl can react with proteins in the cells to form protein carbonyls, an 
irreversible oxidative modification. Carbonyl groups (aldehydes and ketones) may be 
introduced in the protein at different sites and by different mechanisms (Dalle-Donne et 
al., 2005). One established mechanism is via the breakdown of chloramines to 
aldehydes (Hazen et al., 1998). Oxidative cleavage of proteins by either the α-
amidation pathway or by oxidation of glutamyl side chains can also bring about the 
formation of a peptide in which the N-terminal amino acid is blocked by an α-ketoacyl 
derivative. Direct oxidation of lysine, arginine, proline, and threonine residues into 
ketones or aldehyde derivatives may also yield carbonyl moieties on the protein side 
chains. In addition, carbonyl groups may be introduced into proteins by reactions with 
aldehydes produced during lipid peroxidation, with reactive carbonyl derivatives 
(ketoamines, ketoaldehydes, and deoxyosones) generated as a consequence of the 
reaction of reducing sugars, or from their oxidation products reacting with lysine 
residues of proteins (glycation and glycoxidation reactions). Thus, with the generation 
of protein carbonylation via the various oxidative reactions, the presence of carbonyl 
groups in proteins has therefore been used as a marker of ROS-mediated protein 
oxidation (Berlett et al., 1997). 
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1.5.5 Chlorinated products 
HOCl can also chlorinate aromatic and related amino acids of proteins such as 
tyrosine, tryptophan and histidine to form chlorinated materials. For example, free 
tyrosines and tyrosyl residues of protein can be chlorinated to form mono- or dichloro 
derivatives such as 3-chlorotyrosines and 3,5-dichlorotyrosines (Domigan et al., 1995; 













1.6 HOCl and cell viability 
 
Exposure of mammalian cells to HOCl have shown that it can cause cellular 
dysfunction and kill a wide range of cell types including red cells (Vissers et al., 1994; 
Dallegri et al., 1985), endothelial cells (Tatsumi et al., 1994), epithelial cells (Grisham 
et al., 1990; Abernathy et al., 1995), fibroblasts (Vile et al., 2000) and tumour cells 












The ability of HOCl to induce cell death has been described in cultured human 
umbilical-vein endothelial cells (Vissers et al., 1999), where exposure to high 
concentrations of HOCl caused rapid necrosis, whereas lower concentrations induced 
apoptosis or growth arrest. 
In tumour cells, low concentrations of HOCl is found to disrupt various plasma 
membrane transport functions such as inactivation of glucose and aminoisobutyric acid 
uptake, resulting in the inhibition of ATP and lactate production, and glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) inactivation in the cells (Schraufstätter et al., 
1990). The damage to membrane proteins also leads to loss of homeostatic control of 
ions especially cellular K+ across the plasma membrane, causing cell swelling. At high 
concentrations of HOCl, cell lysis is apparent with the perturbation of plasma 
membrane integrity with preferential leakage of small molecules such as NAD into the 
extracellular medium. There is also general oxidation of –SH, methionine and 
tryptophan residues, loss of ATP, formation of protein carbonyls, and inhibition of 
mitochondrial respiration. 
HOCl-mediated haemolysis of human red cells is found to be in close 
correlation with membrane protein modifications (Vissers et al., 1998). Irreversible 
cross-linking of these modified membrane proteins, such as the anion transport protein 
band 3 and other membrane and cytoskeletal proteins, to form haemolytic pores is 
found to be responsible for the haemolysis.  
Recently, a study of HOCl-mediated mitochondrial dysfunction and apoptosis 
on human hepatoma HepG2 and human fetal liver cells (Whiteman et al., 2005) 
demonstrates that, HOCl induced mitochondrial dysfunction and apoptosis, are 
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dependent on the induction of the mitochondrial permeability transition (MPT). HOCl is 
found to induce mitochondrial swelling and collapse of the mitochondrial membrane 
potential with the concomitant release of cytochrome c. Cell death induced by HOCl 
also exhibit several classical hallmarks of apoptosis, including annexin V labeling, 
caspase activation, chromatin condensation, and cell body shrinkage. The induction of 
apoptosis by HOCl was further supported by the finding that CSA and caspase 
inhibitors prevented cell death. 
Thus, it would be useful to detect both cellular and subcellular mitochondrial 
proteins that are affected by HOCl, and find out how they can contribute to the eventual 
HOCl-mediated cell death. 
 
1.7 Biomarkers of HOCl oxidative & chlorinative stress in diseases and/or cells 
 
Chlorinated compounds are valuable markers for monitoring phagocyte-
mediated oxidative damage because myeloperoxidase is the only human enzyme known 
to generate HOCl at the plasma concentration of halide. Although HOCl can react with 
various biological molecules of the cells to form diverse oxidized and chlorinated 
products, most of these are unstable and thus are not ideal as biomarkers of HOCl. 
HOCl can react rapidly, and fastest with thiols and thioethers to form thiol 
oxidation products and methionine sulfoxide. However, they are not unique and specific 
to this oxidant, except possibly for cyclic sulfonamide formed from the oxidation of 
reduced GSH. Thus, they are not suitable as specific marker for HOCl.  
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Protein carbonyls formed from oxidative reactions of HOCl and its 
intermediates are not ideal too because a variety of other ROS oxidation mechanisms 
can also lead to protein carbonylation.  
Chloramines, as the most favoured chlorinated product of HOCl with amines, 
can be readily reduced back to parent amines by biological reductants such as thiols, 
ascorbate and methionine, and are short-lived in biological fluids. In addition, 
chloramines of α-amino acids can also spontaneously breakdown to aldehydes or 
nitriles. As such, they are unstable and not suitable as a biomarker for HOCl. 
A major limitation of fatty acid and cholesterol chlorohydrins as biomarker is 
the low reactivity of the alkene bonds, which compete very poorly with other targets for 
HOCl. Another limitation is that lipid chlorohydrins is only detectable at HOCl 
concentrations well above cytotoxic concentrations and those required for protein 
modifications, thus raising doubts that lipid chlorohydrins might not be able to be 
detected at physiologically relevant HOCl doses. Also, lipid chlorohydrins are not 
completely stable as they can form epoxides under mild alkaline conditions. 
Lastly, chlorinated products of aromatic and related amino acids of proteins 
seem to be ideal biomarkers for HOCl because they retain chlorine, but those of 
tryptophan and histidine are unstable (Davies, 2005). The only ideal stable biomarkers 
are chlorinated tyrosines such as 3-chlorotyrosine and 3,5-dichlorotyrosines as they not 
only retain chlorine but are also stable under the acid conditions required to hydrolyze 
proteins (Winterbourn et al., 2000). Their suitability as biomarkers can be further 
established by the demonstration of markedly elevated levels of 3-chlorotyrosine 
detected in LDL from atherosclerotic intima (300 chlorotyrosines/million tyrosyl 
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residues) when compared with levels in peripheral blood LDL (10 
chlorotyrosines/million tyrosyl residues) (Hazen et al. 1997). But because they are 
minor products of HOCl-modified proteins, sensitive methods are required to detect and 
measure its level in proteins. As 3-chlorotyrosines can be converted to 3,5-
chlorotyrosines at high concentrations of HOCl, measurement of both of these 
chlorinated tyrosines will provide a more complete assessment of the extent of protein 
chlorination. 
Although several studies have been performed to detect and quantitate the 
various HOCl-mediated oxidative/chlorinative products in cells and a number of 
inflammatory tissues, for example chlorotyrosines, using gas chromatography with 
mass spectrometry (GC/MS) and liquid chromatography - electrospray ionization 
tandem mass spectrometry (LC/ESI-MS) (Gaut et al., 2002; Pietzsch et al., 2003), there 
has yet been a study to identify extensively the cellular proteins that are being 




Proteomics is the large-scale study of the regulation, expression, localizations, 
functions, post-translational modifications and interactions of the proteins expressed by 
the genetic material of an organism or a given cell type under defined conditions. While 
proteomics is often viewed as the downstream study from genomics, it is much more 
complicated than the latter. With the completion of the sequencing of the human 
genome (International Human Genome Sequencing Consortium, 2001; 2004), many 
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researchers are now looking at how genes and proteins interact to form other proteins. A 
surprise finding of far fewer protein-coding genes in the human genome than there is 
proteins in the human proteome (20,000-25,000 protein-coding genes vs. >100,000 
proteins), suggests that the large increase in protein diversity might be possibly due to 
the alternative splicing and post-translational modification (PTM) of proteins. 
Alternative splicing of a gene product and PTM can give rise to numerous isoforms of 
the same protein, and can possibly modify the function of a protein. Thus, this 
discrepancy implies that protein diversity cannot be fully characterized by gene 
expression analysis alone, making proteomics a useful tool for characterizing cells and 
tissues of interest. 
While the genome is a rather constant entity, the proteome (PROTEin 
complement to a genOME) is dynamic and differs from cell to cell. It is constantly 
changing through its biochemical interactions with the genome and the environment, 
especially when the cells are under a particular type of stimulation. Furthermore, it is 
proteins but not mRNA, which is the workhorse of a cell that carries out its biological 
functions. Therefore, using a proteomics approach to identify differences between 
normal and diseased state, can help to relate these differences to the disease pathways 
and further unravel the biological processes. 
 
1.8.1 2-Dimensional polyacrylamide gel electrophoresis (2-DE) 
  
An established method of protein separation in proteomics is the use of 2-
dimensional polyacrylamide gel electrophoresis (2-DE). It is a powerful and widely 
used method for the analysis of complex protein mixtures extracted from cells, tissues 
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or other biological samples. This technique separates proteins according to two 
independent properties in two discrete steps. The first step, isoelectric focusing (IEF), 
separates proteins according to their isoelectric points (pI), while the second step, SDS-
polyacrylamide gel electrophoresis (SDS-PAGE), separates the proteins according to 
their relative molecular weights. In this way, each spot on the resulting two-dimensional 
array then corresponds to a single protein species in the sample. Proteins with their pI 
and/or molecular weights close to each other can also be resolved in a large gel format 
with narrow pI range. Thousands of different proteins can thus be resolved with this 
method, and information such as their pI, molecular weights and the relative amount of 
each protein can also be obtained. Therefore, 2-DE is advantageous in determining 
protein isoforms and post-translational modifications (PTMs) which might have 
characteristics of pI and/or relative molecular weight changes.  
One inherent problem of 2-DE gels comparison is gel-to-gel variation. It is 
almost impossible to overlay two different gels completely and compare the expression 
levels of the proteins. To overcome this limitation, an advanced technique namely two-
dimensional difference gel electrophoresis (2-D DIGE) has been developed. 2-D DIGE 
allows multiplex analysis of different samples in one experiment, and in a single gel. It 
involves the use of fluorescent dyes to label proteins samples followed by separation of 






1.8.2 2-dimensional difference gel electrophoresis (2-D DIGE) 
 
There are three spectrally resolvable CyDye DIGE fluors namely Cy2, Cy3 and 
Cy5, which are matched for charge and molecular weight. This means that the same 
protein when labeled with any of the CyDye DIGE fluors, will migrate to the same 
position on a 2-D gel.  As all three dyes have different excitation and emission 
wavelength, they can be displayed on a single gel after scanned when all three channels 
are turned on. This feature enables multiplexing of up to three separate protein mixtures 
on the same 2-D gel, and eliminates gel-to-gel variation. The CyDye fluors have an 
NHS ester reactive group, designed to covalently bond to the epsilon amino group of 
lysine of proteins via an amide linkage, labeling 1-2% of lysine residues. The dyes give 
great sensitivity with detection of about 125 pg of a single protein, with a linear 
response in protein concentration over at least five orders of magnitude, as compared to 
1-60 ng with less than a 102 dynamic range for silver stain (Ettan™ DIGE product 
manual, GE Heathcare Biosciences).  
2-D DIGE enables the incorporation of the same internal standard on every 2-D 
gel in one experiment. The internal standard contains a pool of all the samples within 
the experiment, consisting of every protein from every sample. The internal standard is 
used to match the protein patterns across gels thereby negating the problem of inter-gel 
variation, a problem intrinsic to standard 2-D gel assays. Cy2 fluor is usually used to 
label the standard pool of protein samples, while Cy3 and Cy5 are used to label the 
samples for comparison, e.g. Cy3 for control sample vs Cy5 for treated sample. The 
internal standard is also used to normalize the different samples on every gel, thus 
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allowed accurate quantitation of differences between samples with an associated 
statistical significance. 
Software designed for the 2-D DIGE system, Decyder, contains proprietary 
algorithms that perform co-detection of differentially labeled samples within the same 
gel. It allows automated detection, background subtraction, quantitation, normalization 
and inter-gel matching, thus providing easy comparison of the 2D-DIGE gels. 
 
1.8.3 Mass Spectrometry 
 
Mass spectrometry (MS) is an analytical technique employed to measure the 
mass-to-charge ratio of ions. It is generally used to characterize protein samples by 
generating a mass spectrum representing the masses of the components present in the 
sample. This is achieved by ionizing the sample thus separating ions of differing masses, 
and recording their relative abundance by measuring intensities of the ion influx. 
Identification of the proteins in the sample is then made possible by acquiring accurate 
mass information either on the intact protein itself or its digested peptides (usually 
digested by trypsin). Protein peptides have distinctive fragmentation patterns which 
allows sequence information to be obtained in which identity can be ascertained upon 
by searching with specific databases. 
A commonly used method in mass spectrometry to identify proteins in 
proteomics is the matrix-assisted laser desorption/ionization-time of flight mass 
spectrometry (MALDI-TOF/MS). It essentially consists of a MALDI source that 
enables ionization of peptides or proteins with the aid of a matrix (small organic 
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molecules that strongly absorb ultraviolet laser light that is introduced with short intense 
pulses), and a TOF analyzer tube that can boost ions to the same kinetic energy by 
passage through an electric field and then measures the time the ions take to reach the 
detector.  While the nominal kinetic energy of all the ions is the same, the resultant 
velocity is different, thereby causing lighter ions and also more highly charged ions to 
reach the detector first. This produces high resolution and accurate measurement of the 
ion masses of the peptides or proteins of interest. Advancement in recent technologies 
has lead to the development of a new MALDI with a tandem TOF system that provides 
MS/MS capability known as MALDI-TOF/TOF mass spectrometer. Basically, this 
system is similar to a MALDI-TOF system except for an additional TOF tube and a 
collision cell between the flight tubes that enables tandem MS (MS/MS) to be 
performed. Peptides are ionized in the MALDI source and are separated by mass on the 
first TOF. The parent ions are then selected and allowed to enter the collision cell, 
whereby they collide with gas molecules and are further fragmented to their daughter 
ions by collision-induced dissociation. This is followed by analysis on the second TOF. 
In this way, sequence information of the peptide can be obtained and the protein can be 
more confidently identified by searching against the human protein databases using the 
MASCOT search engine. 
Another method of identifying proteins is using a nanoLC-MS/MS system. In 
this method, the protein sample is digested and the resulting peptide mixture is analysed 
by reverse phase liquid chromatography (RP-LC) coupled on-line to an electrospray 
ionization mass spectrometer (ESI-MS/MS). The C18 nano-capillary column material 
(75 µm internal diameter x 100 mm length) is packed with material of 5 µm in particle 
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size. The sample is injected at a flow rate of 90µL/min into the HPLC system whereby 
the peptides are fractionated on the basis of hydrophobicity, and analyzed by the first 
mass spectrometer (MS-1) which employed a quadrupole mass filter tuned to allow only 
the peptide ion of interest to pass through. This peptide is then taken into a collision cell 
where nitrogen gas is used to fragment the peptide, and the daughter ions are then swept 
into a second time-of-flight MS (MS-2) where they are separated and detected. The 
protein sequence information is then obtained and searched against human protein 
databases using the MASCOT search engine. 
 
1.8.4 Identification of proteins  
 
Proteins can be digested by endo-proteases such as trypsin and pepsin, which 
recognize specific amino acid residues, and give rise to specific sequences. The 
commonly used protease, trypsin, cleaves exclusively at the C-terminal of a lysine or 
arginine molecule except when there is a proline residue after them. With the specific 
peptide cleavage, a list of the proteolytic peptide masses of the protein of interest can be 
used as input, to perform a search on protein databases with predicted masses that arise 
from digestion of a list of known proteins, to determine the identity of the protein of 
interest. This is known as peptide mass fingerprinting (PMF). If a significant number of 
the predicted masses of a protein sequence in the reference list match the experimental 
values, we can safely confirm the protein identity. However, further confirmation 
should be done using tandem MS where the protein peptide is fragmented to give rise to 
its peptide amino acid sequences. In short, tandem MS provides a better confidence in 
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identifying an unknown protein as it matches the actual sequence of the protein in the 
database. 
There are many public and private databases containing protein data ranging 
from sequences, to functions, to post translational modifications. UniProt 
Knowledgebase: Swiss-Prot and TrEMBL, developed in collaboration between the 
Swiss Institute of Bioinformatics and the European Bioinformatics Institute, are 
currently the major databases dedicated to cataloging protein data. Swiss-Prot is a 
curated non-redundant database, which contains information on the properties of the 
proteins such as function, cellular localization and possible post-translational 
modifications, with a minimal level of redundancy and high level of integration with 
other databases. TrEMBL is a computer-annotated supplement of Swiss-Prot that 
contains all the translations of EMBL nucleotide sequence entries not yet integrated in 
Swiss-Prot. Another widely used database is the International Protein Index (IPI) human 
protein database v3.14. It effectively maintains a database of cross references between 
the primary data sources and provides minimally redundant yet maximally complete 
sets of proteins for featured species (one sequence per transcript), and maintains stable 
identifiers (with incremental versions) to allow the tracking of sequences in IPI between 







1.9 Proteome analysis of HOCl-induced oxidative stress response in human 
HepG2 cell line. 
 
There is extensive evidence for a pathophysiological role for HOCl in vivo (Buss 
et al., 2003; Chapman et al., 2002) including the demonstration of chlorinated protein 
tyrosine residues such as 3-chlorotyrosine, and HOCl-modified proteins in a number of 
inflammatory tissues (Buss et al., 2003; Brown et al., 2001; Gujral et al., 2003; Gujral 
and Hinson et al., 2004; Pullar et al., 2000). These inflammatory sites include septal 
and periseptal hepatocytes and Kupffer cells of cirrhotic human liver (Brown et al., 
2001), as well as in the hepatocytes and parenchymal cells in murine models of 
endotoxemia (Gujral, Hinson, and Farhood et al., 2004). 
Several of these studies have been carried out to study specific proteins that are 
oxidatively modified and/or inactivated by HOCl produced by myeloperoxidase using 
various cell lines and inflammatory tissues (Hazell et al., 1999; Dallegri et al., 1988; 
Heinecke, 1997; Vile et al., 2000). But to our knowledge, this report is the first attempt 
at studying the differential protein expression in the human hepatoma cell line, HepG2, 
upon HOCl treatment, on a global level.  
Thus, in this study, we aim to (1) profile the differentially expressed proteins of 
HepG2 cells upon exposure to 30 µM and 60 µM of HOCl, (2) locate and identify the 
oxidized / carbonylated proteins and (3) identify those proteins that are being 
chlorinated by HOCl. Besides focusing our work on the whole cell proteome, we also 
explored the mitochondrial sub-proteome of the HOCl-treated HepG2 cells. We have 
adopted the 2-dimensional difference gel electrophoresis (2D-DIGE) (Amersham 
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Biosciences, GE Healthcare) to detect the differentially expressed proteins for the 
control versus treated samples, while the oxidized/ carbonylated proteins were 
derivitized first with 2,4-dinitrophenylhydrazine (DNPH) and detected by western 
blotting. The differentially expressed and immunoreactive protein spots were then 
identified using mass spectrometry. 
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2.  MATERIALS AND METHODS 
 
2.1 Materials 
The human hepatoma HepG2 cell line was purchased from the ATCC (American Type 
Culture Collection, Rockville, MD, USA) 
 
2.1.1 Instruments and Equipments 
2.1.1.1 Isoelectric Focusing (IEF)  
 
Ettan IPGphor / IPGphor II IEF unit (GE Healthcare Bio-Sciences, formally known as 
Amersham  Biosciences, Uppsala, Sweden) 
 
Pre-cast Non-Linear (NL) 18 cm Immobilized pH Gradient (IPG) strips, pH 3-10 (GE 
Healthcare Bio-Sciences, Uppsala, Sweden) 
 
2.1.1.2 SDS-PAGE  
 
PROTEAN-II XL electrophoresis cell (Bio-Rad Laboratories, Hercules, CA, USA) 
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2.1.1.3 Mass Spectrometry  
Perspective Biosystems Voyager-DE STR matrix-assisted laser desorption/ionization 
time-of-flight mass spectrometer (MALDI-TOF-MS) (Applied Biosystems, Framingham, 
MA, USA) 
 
Applied Biosystems 4700 Proteomics Analyzer [Matrix-assisted laser desorption/ 
ionization time-of-flight/time-of-flight mass spectrometer (MALDI-TOF/TOF-MS)] 
(Applied Biosystems, Framingham, MA, USA) 
 
nano LC analytical system (LC Packings-ADionex Company) coupled to a Q-Star XL MS 




Semiphor transfer unit (GE Healthcare Bio-Sciences, Uppsala, Sweden) 
 
Trans-Blot Cell (Bio-Rad Laboratories, Hercules, CA, USA) 
 
2.1.1.5 Centrifuges  
 




Materials and Methods 33
2.1.1.6 Scanners 
 
UMAX ImageScanner (UMAX Technologies Inc.) (Fremont, CA, USA) 
 
Molecular Dynamics TYPHOON 9410 variable mode Imager (GE Healthcare Bio-
Sciences, Sunnyvale, CA, USA). 
 
2.1.1.7 Centrifugal Concentrator 
 
Thermo Savant SPD Speed-vac® SPD121P centrifugal concentrator (Holbrook, NY, USA) 
 




Cell Culture Reagents Source 
Fetal Bovine Serum (FBS) HyClone (Logan, Utah, USA) 
Minimum Essential Medium (MEM) Sigma Aldrich (St. Louis, MO, USA) 
Penicillin/Streptomycin Sigma Aldrich 
Sodium Bicarbonate Sigma Aldrich 
Trypsin (+ EDTA) GIBCO BRL (Gaithersburg, MD, USA) 







2.1.3 General Chemicals and Reagents  
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Chemicals & Reagents Source 
2D Cleanup Kit GE Healthcare Bio-Sciences, Uppsala, 
Sweden 
 
2,4-Dinitrophenylhydrazine (DNPH), 50% 
moist with water 
 
Sigma Aldrich 
α-cyano-4-hydroxycinnamic acid (CHCA) Sigma Aldrich 
Acetic acid Merck (Darmstadt, Germany) 
Acetonitrile EM Science (Gibbstown, NJ, USA) 
Ammonium bicarbonate Sigma Aldrich 
Ammonium Persulfate (APS) Bio-Rad Laboratories (Hercules, CA, USA) 





Coomassie® Plus Protein Assay Reagent Kit Pierce, Rockford, IL, USA 
Cover Fluid GE Healthcare Bio-Sciences 
Cy3 N-hydroxysuccinamide ester DIGE dyes 
(Cy3) 
 
GE Healthcare Bio-Sciences 
Cy5 N-hydroxysuccinamide ester DIGE dyes 
(Cy5) 
 
GE Healthcare Bio-Sciences 
Cy2 N-hydroxysuccinamide ester DIGE dyes 
(Cy2) 
 
GE Healthcare Bio-Sciences 
Dimethyl sulphoxide (DMSO) Sigma Aldrich 
Dithiothreitol (DTT) Bio-Rad Laboratories 
DNase I Boehringer Mannheim (Mannheim, 
Germany) 
 
EDTA disodium dihydrate Bio-Rad Laboratories 
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Formaldehyde Merck 
Glycerol BDH laboratory Supplies (Poole, England) 
Glycine Merck 
Glycine, ultrapure, MB Grade USB 
HALT™ protease inhibitor cocktail (100X) Pierce 
Hydrochloric acid Merck 
HOCl (Sodium Hypochlorite Solution) Honeywell Riedel-de-Haen (Seelze, 
Germany) 
 
Iodoacetamide (IAA) Sigma Aldrich 
IPG buffer GE Healthcare Bio-Sciences 
Methanol Merck 
Mitochondria Isolation kit (MITO-ISO1) Sigma Aldrich 
NAP™-25 Column GE Healthcare Bio-Sciences 
RNase A Boehringer Mannheim 
Seaplaque® GTG® Agarose, Low melting 
temperature agarose 
 
BMA ( Rockland, ME, USA) 
Silver Nitrate Merck 
Skimmed Milk Anlene 
Sodium carbonate Merck 
Sodium dodecylsulfate (SDS) Bio-Rad 
Sodium thiosulfate Merck 
SYPRO Ruby protein gel stain Molecular Probes (Eugene, OR, USA) 
Thiourea Fluka Chemie (Buchs, Switzerland) 
Tris(hydroxymethyl)-aminomethane (Tris) J.T. Baker (Phillipsburg, NJ, USA) 
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Tris(hydroxymethyl)-aminomethane (Tris) 
ultrapure, MB Grade 
 
USB 
Trifluoroacetic acid (TFA) Sigma Aldrich 
Trypsin Promega Corporation (Madison, WI, USA) 
Urea Bio-Rad Laboratories 
Urea, ultrapure, MB Grade USB 
 
All chemicals and biochemicals used were of analytical or GR grade, unless stated 
otherwise. 
 






Rabbit anti-Dinitrophenyl (DNP) delipidized 
whole anti-serum 
Sigma Aldrich 
Mouse anti-GRP75, monoclonal IgG Stressgen (Victoria, BC Canada, USA) 
Mouse anti-pyruvate dehydrogenase (PDH) 
E1α subunit IgG1, monoclonal 9H9 
 
Molecular Probes 
Rabbit anti-actin, polyclonal IgG Santa Cruz Biotechnology Inc. (Santa Cruz, 
CA, USA). 
 
Rabbit anti-glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH), FL, polyclonal 
IgG 
 
Santa Cruz Biotechnology Inc. 
Rabbit anti-Hsp27 polyclonal IgG Santa Cruz Biotechnology Inc.  
Goat anti-rabbit IgG, HRP conjugated Santa Cruz Biotechnology Inc.  
Sheep anti-mouse IgG, HRP conjugated GE Healthcare Bio-Sciences 
2.1.4.2 Detection system 
Materials and Methods 37
 
ECL-Advanced Western blotting detection system (GE Healthcare Bio-Sciences). 
 
ECL Western blotting detection system (GE Healthcare Bio-Sciences). 
 
2.1.5 Softwares & Databases 
2.1.5.1 Image Analysis 
ImageQuant software (GE Healthcare Bio-Sciences) 
 
DeCyder v 5.02 and v 6.0 software (GE Healthcare Bio-Sciences) 
 
2.1.5.2 MS Data Analysis 
 
MS-FIT; Protein Prospector (UCSF, San Francisco, CA, USA) 
(http://prospector.ucsf.edu/ucsfhtml3.4/ms-fit.htm) 
GPS Explorer V2.0 software (Applied Biosystems)  
 
MASCOT V1.9 (Matrix Science Ltd., London, UK) 
 
UniProt Knowledgebase: Swiss-Prot and TrEMBL (Swiss Institute of Bioinformatics, 
Geneva, Switzerland; European Bioinformatics Institute, Hinxton, UK) 
 
International Protein Index (IPI) human protein database (European Bioinformatics 
Institute, Hinxton, UK)  
 
Systematic Proteomics Laboratory Analysis & Storage Hub (SPLASH) (Oncoproteomics 
Centre, DBS, NUS) 
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2.2  Methods 
 
2.2.1 HepG2 Cell Culture 
 
HepG2 cells were cultured in complete minimal essential medium (MEM) 
supplemented with 2.2 g sodium bicarbonate, 1% (v/v) penicillin / streptomycin, 10% 
fetal bovine serum (FBS), pH 7.4, under standard cell culture conditions (37°C, 5% CO2).  
 
2.2.2 HepG2 Cells Treatment  
 
Upon 85% - 90 % cell confluence, complete MEM was removed and the cells were 
washed twice with 1x PBS. HOCl was serial-diluted from stock concentration of 1M to 60 
µM and 30 µM concentrations with PBS. The cells for treatment were then exposed to 30 
µM and 60 µM HOCl in PBS for 20 minutes respectively. The control cells were 
incubated concurrently in fresh PBS during the 20 minutes treatment. The treatment 
solutions were decanted and cells were then harvested via cell scrapping in fresh PBS with 
HALT™ protease inhibitor cocktail. The cells were washed twice with PBS to remove 
excess HOCl, and pelleted at 1,500 rpm, 15°C for 5 minutes. 
 
 
2.2.3 Sample Preparation  
 
 
2.2.3.1 Whole Cell Lysis 
 
 
HepG2 cells pellets were lysed in 2DE lysis buffer containing 7 M urea / 2 M 
thiourea, 4 % 3-(3-cholamidopropyl)dimethyammonio-1-propane (CHAPS), 40 mM Tris, 
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50 µg/ml DNase, 50 µg/ml RNase and 1X HALT™ protease inhibitor cocktail. The lysate 
was centrifuged at 20,000 xg at 15 °C for 1 h to remove cell debris. The supernatant was 
then aliquoted into 100 µl / tube and stored under -80 °C. 
 
2.2.3.2 Mitochondria Enrichment 
 
Mitochondria fraction was enriched from HepG2 cells using the Mitochondria 
Isolation kit (MITO-ISO1) with slight modification to the recommended protocol 
provided with the kit. The whole procedure was carried out on ice. Approximately 3.8 x 
108 control & 60µM HOCl treated HepG2 cells were harvested as described in section 
2.2.2 and resuspended in Extraction Buffer A ( 10mM HEPES pH 7.5 containing 200mM 
mannitol, 70mM sucrose & 1mM EGTA ) with HALT™ protease inhibitor cocktail. The 
cells were lysed in a Parr Nitrogen Bomb (Parr Instrument Co., Moline, IL) that was kept 
cold on ice. The bomb was first pressurized to 300 p.s.i. with nitrogen, and then allowed 
to equilibrate for 30-35 minutes with constant stirring from a magnetic stir bar added into 
the chamber. Finally, the release of the sample from the bomb would cause complete cell 
lysis. (Hunter and Commerford, 1961) The cell lysate were then collected in 2ml 
microfuge tubes and centrifuged at 1,000 xg for 5 minutes to remove cell debris. The 
supernatant was then transferred to a new tube and centrifuged at 3,500 xg for 10 minutes 
to pellet down the mitochondria. The pellet was resuspended in Extraction Buffer A and 
centrifuged again at 1,000xg for 5 minutes to remove any remnant cell debris. The 
supernatant was eventually centrifuged at 3,500 xg for 10 minutes to pellet down the 
enriched mitochondria fraction, which was solubilized in 2-DE lysis buffer containing 7 
M urea / 2 M thiourea, 4 % 3-(3-cholamidopropyl)dimethyammonio-1-propane (CHAPS), 
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10 mM Tris, 50 µg/ml DNase, 50 µg/ml RNase and HALT™ protease inhibitor cocktail. 
The protein samples were then aliquoted into tubes and stored under -80 °C. 
 
2.2.4 Protein Estimation 
 
 
Protein estimation of the protein samples was carried out using Coomassie® Plus 
Protein Assay Reagent Kit. Bovine serum albumin (BSA) provided in the kit was used as 
standard at a range of 100 µg/ml – 250 µg/ml. 
 
 
2.2.5 2-Dimensional Difference Gel Electrophoresis (2-D DIGE) 
 
2.2.5.1 Sample Labeling with CyDye DIGE Fluors (minimal dyes) 
 
Protein labeling for DIGE was carried out as described in the Ettan DIGE User 
Manual (18-1164-40 Edition AA). The pH of the protein lysates were checked on pH 
indicator strips to ensure that the pH were in a range of pH 8.0 - 8.5, so as to facilitate 
optimal labeling of the protein samples with the CyDye Fluors. pH of the samples that 
were below pH 8.0 were increased to pH 8.5 by careful addition of 50 mM sodium 
hydroxide (NaOH). Alternatively, we could also make an identical lysis solution, (7M 
urea, 2M thiourea, 4% CHAPS, 40mM Tris [without the protein]) at pH 9.5, and mix 
increasing volumes of this new lysis solution with the protein samples until it reached a 
pH of 8.5. Equal amounts (50 µg) of the control and treated protein samples were labeled 
with 400 pmoles of Cy3 and Cy5 DIGE fluors respectively, with an internal standard of 
pooled samples containing equal amounts of all samples, labeled with Cy2 (Table 1 & 
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Table 2). The labeling reaction was carried out in an ice-bath, in the dark for 30 min, and 
terminated by adding 1 µl of 10 mM L-lysine per reaction, and incubated on ice for 10 
minutes. The samples were then stored in -80 °C until 2D gel electrophoresis. 
 
Gels Standard - Cy2 (50µg) 
Samples - Cy3 
(50µg) 
Samples - Cy5 
(50µg) 
1. Pooled Samples (1-4) (1) Control (2) 30µM HOCl Treated
2. Pooled Samples (1-4) (1) Control (2) 30µM HOCl Treated
3. Pooled Samples (1-4) (1) Control (2) 30µM HOCl Treated
4. Pooled Samples (1-4) (3) Control (4) 60µM HOCl Treated
5. Pooled Samples (1-4) (3) Control (4) 60µM HOCl Treated
6. Pooled Samples (1-4) (3) Control (4) 60µM HOCl Treated
 
Table 1. Experimental design of the 2D-DIGE gel runs for HepG2 Whole Cell 
Lysates.  
Each treatment and its control was run in 3 replicates. 
 
 
Gels Standard - Cy2 (50µg) 
Samples - Cy3 
(50µg) 
Samples - Cy5 
(50µg) 
1. Pooled Samples (1-4) (1) Control, B1 (2) 60µM HOCl Treated, B1
2. Pooled Samples (1-4) (1) Control, B1 (2) 60µM HOCl Treated, B1
3. Pooled Samples (1-4) (1) Control, B1 (2) 60µM HOCl Treated, B1
4. Pooled Samples (1-4) (3) Control, B2 (4) 60µM HOCl Treated, B2
5. Pooled Samples (1-4) (3) Control, B2 (4) 60µM HOCl Treated, B2
6. Pooled Samples (1-4) (3) Control, B2 (4) 60µM HOCl Treated, B2
 
Table 2. Experimental design of the 2D-DIGE gel runs for enriched HepG2 
mitochondrial protein fractions. There are two batches of treated samples (B1 and B2), 
and both with its control were run in 3 replicates. 
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2.2.5.2 First Dimension - Isoelectric Focusing (IEF) 
 
IEF was performed on pre-cast 18 cm pH 3-10 NL IPG strips using the Ettan 
IPGphor / IPGphor II IEF unit. For each strip, 50µg of each of the labeled control (Cy3), 
treated (Cy5) and standard (Cy2) samples were mixed together before being topped up 
with rehydration buffer (7 M urea, 2 M thiourea, 4% w/v CHAPS, trace amount of 
bromophenol blue), 20 mM DTT and 0.5% v/v pH 3- 10 NL IPG buffer, to a total volume 
of 350 µl. The samples were in-gel rehydrated onto the IPG strips in an Ettan IPGphor 
Conventional Ceramic Strip Holder, at a low voltage of 30V for 6.5 hours, followed by 
60V for another 6.5 hours. The rehydrated strips were then transferred to the Ettan 
IPGphor Ceramic Cup Loading Strip Holder for isoelectric focusing. Electrode pads 
wetted with de-ionized water and then blotted almost completely dry were placed on each 
end of the IPG strips. These electrode pads served to absorb excess water and salt during 
the run, as well as proteins with pI that are outside the pH range of the IPG strips. The 
electrodes were then slide down on each of the pads and the strips were then flooded with 
4 ml of mineral oil. Isoelectric focusing was then carried out to a total of 55,100 Vhrs with 
the following parameters: (i) 200V, 100 Vhrs; (ii) 500 V, 250 Vhrs; (iii) 1000 V, 500 Vhrs; 
(iv) 1000 V- 8000 V, 2250 Vhrs and (v) 8000 V, 52 000 Vhrs. Voltage increase were on a 
step-wise basis for all steps except for step (iv) which was on a linear gradient mode. The 
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2.2.5.3 Second Dimension - SDS-PAGE 
 
Before carrying out the second dimensional run, the IPG strips were subjected to a 
two-step equilibration procedure. The IPG strips were first equilibrated in an equilibration 
buffer containing 6M urea, 30% (v/v) glycerol, 2% (w/v) SDS, 50 mM Tris-HCl (pH 6.8), 
and 1% (w/v) DTT, a reducing step to break the protein disulfide bonds.  The strips were 
then transferred to an equilibration buffer containing 6M urea, 30% (v/v) glycerol, 2% 
(w/v) SDS, 50 mM Tris-HCl (pH 8.8), and 2.5% (w/v) IAA, to alkylate the thiol groups of 
the proteins to prevent their re-oxidation during electrophoresis. After the strips were 
transferred onto the second dimensional SDS-PAGE gel (Appendix I), the strips were 
sealed with 0.75 % (w/v) agarose dissolved in Tris-glycine SDS-PAGE running buffer 
(0.0025 M Tris, 0.0192 M glycine, 0.01 % w/v SDS, pH 8.3), with trace amount of 
bromophenol blue. SDS-PAGE was conducted in 1.0 mm thick, 12 %T polyacrylamide 
gel, run in 4.1 litres of Tris-glycine SDS-PAGE running buffer (0.0025 M Tris, 0.0192 M 
glycine, 0.01 % w/v SDS, pH 8.3) using the PROTEAN-II XL electrophoresis cell.  All 
six gels were conducted on the same run in the dark at 30 mA per gel and cooled at 10 °C. 
After electrophoresis, the gels were wrapped together using plastic wrap, with the glass 
plates undetached, and kept in dark before image acquisition on the TYPHOON 9410 
variable mode Imager. 
 
2.2.5.4 Image Acquisition 
 
The gels (still sandwiched between the glass plates) were imaged on the Molecular 
Dynamics Typhoon 9400 variable mode imager using the fluorescence scan acquisition 
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mode, at the optimal excitation/emission wavelengths for each CyDye fluors (Cy2, 
488/520 nm; Cy3, 532/580 nm; Cy5, 633/670 nm). The gels were scanned at pixel size of 
100 microns. The first gel was used to calibrate the laser intensity according to the Ettan 
DIGE User Manual. For each gel, three separate images were acquired, giving a total of 
18 gel images for each image analysis set. The images were then viewed with the 
ImageQuant software.  
 
2.2.5.5 Image Analysis 
 
DeCyder v 5.02 and v 6.0 software were used to analyze the DIGE images as 
described in the Ettan DIGE User Manual. The DIGE images underwent spot detection 
and quantitation in the differential in-gel analysis (DIA) module, with an average of 2200 
spots per gel detected. The matched images were next analyzed in the biological variation 
analysis (BVA) module, which provided statistical data of the differentially expressed 
spots. The spots on each standard gels were screened through thoroughly to ensure that 
they were matched correctly across the gels. The spots on the gels were analyzed and 
compared based on statistical tests such as Average ratio, Student’s T-test and One-way 
ANOVA. Differentially expressed protein spots were selected and confirmed based on a 
cutoff limit of ≥ 1.4 fold-difference between control and treated samples, with a statistical 
significance of p<0.05, and they must be consistently present and shown to be 
differentially expressed in at least five out of the six gels. The confirmed spots were then 
excised for MS from fresh non CyDye-labelled 2DE gels, which were run with parameters 
as described in section 2.2.5.2 & 2.2.5.3, and silver stained as described in section 2.2.7. 
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2.2.6 Detection of Oxidized / Carbonylated proteins 
 
2.2.6.1 DNPH Derivitization of Carbonylated proteins 
 
400 µg of the respective control and treated protein samples were derivatized with 
80 µl of 10 mM DNPH in 2N HCl, at room temperature for 1 hour (Yan et al., 1998). 
Excess DNPH were removed from the derivatized samples via TCA-acetone precipitation 
using the 2D Cleanup kit. The protein recovery of the cleaned up samples were then 
estimated as described in section 2.2.4. 
  
2.2.6.2 2-Dimensional Gel Electrophoresis 
 
IEF of the DNPH derivatized protein samples were performed on pre-cast 18 cm 
pH 3-10 NL IPG strips using the Ettan IPGphor / IPGphor II IEF unit, as described in 
section 2.2.5.2. The only difference is that the strips were first rehydated overnight 
(minimum of 10 hours) with 350 µl of rehydration buffer (7 M urea, 2 M thiourea, 4% w/v 
CHAPS, trace amount of bromophenol blue ), 20 mM DTT and 0.5% v/v pH 3- 10 NL 
IPG buffer, prior transfer to the Ettan IPGphor Ceramic Cup Loading Strip Holder (gel 
face up) whereby 150µg of the samples were introduced via sample cup loading at the 
anodic end of the each strip for isoelectric focusing. IEF was carried out to a total of 
40,150 Vhrs with the following parameters: (i) 200V, 400 Vhrs; (ii) 500 V, 1000 Vhrs; (iii) 
1000 V, 500 Vhrs; (iv) 1000 V- 8000 V, 2250 Vhrs and (v) 8000 V, 36 000 Vhrs. Voltage 
increase were on a step-wise basis for all steps except for step (iv) which was on a linear 
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gradient mode. The strips were then kept in -80 °C until second dimension, which is 
performed as described in section 2.2.5.3. 
 
2.2.6.3 Protein Transfer to Nitrocellulose Membrane 
 
The gels after the SDS-PAGE run, were removed from the glass plates and 
incubated in transfer buffer (0.0025 M Tris, 0.0192 M Glycine, 0.01 % w/v SDS, pH 8.3 
and 20% methanol), with gentle shaking for 5 minutes at room temperature. Nitrocellulose 
membranes & blotting papers trimmed to 18.4cm by 19.2cm were also pre-soaked in 
transfer buffer for 5 minutes at room temperature. The proteins were then transferred onto 
the nitrocellulose membranes at 0.8mA/cm2 for 1 hour (set at a limit of 50V) using the 
Semiphor transfer unit, or 100V for 45-60 minutes, using the Trans-Blot Cell. 
 
2.2.6.4 Western Blotting and detection 
 
The membranes were blocked in 5% (w/v) skimmed milk at room temperature 
with shaking for 1 hour, and kept at 4°C overnight. The subsequent steps were carried out 
with shaking at room temperature. The membranes were first rinsed with TBST (20mM 
Tris-HCl, 137mM NaCl, 0.1% Tween20, pH 7.5) for 1 minute, followed by washing in 
TBST for 10 minutes. They were then incubated with rabbit anti-DNP primary antibodies 
(1:20,000 in TBST, 0.2% BSA) for 1 hour and the excess rinsed off with TBST. The 
membranes were then washed 3 X 10 minutes with TBST. This was followed by 
incubation with goat anti-rabbit HRP-conjugated antibodies (1:2,500 in TBST, 0.2% BSA) 
for 1 hour. The excess were rinsed off with TBST and washed 3 X 10 minutes with TBST 
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prior to detection & visualization using the ECL Western blotting detection system on x-
ray films. 
 
2.2.7 Silver Staining 
 
Gels after DIGE image acquisition and/or gels meant for protein spots excision for 
MS analysis were silver stained based on Vorum’s protocol [Mortz et al., 2001], but with 
modifications. The steps were all done with gentle shaking, unless otherwise stated. The 
gels were first fixed in fixing solution containing 50% (v/v) methanol, 12% (v/v) acetic 
acid, 0.05% formalin in water for 2 hours or overnight. The gels were then washed in 35% 
(v/v) ethanol for 3 X 20 minutes before sensitization for 2 minutes with 0.02% (w/v) 
sodium thiosulphate solution. Excess sodium thiosulphate were then rinsed off with 3 
changes of Milli-Q water for 5 minutes each before incubated in 0.2% (w/v) silver nitrate, 
0.076% (v/v) formalin for 20 minutes. After silver nitrate incubation, excess silver nitrate 
were rinsed off with 2 changes of water for 1 min each prior to development with a 
solution containing 6% (w/v) sodium carbonate, 0.004% (w/v) sodium thiosulphate, 
0.05% (v/v) formalin, with intensive shaking. The gels were developed to the desired 
intensity followed by termination of the reaction with 0.039% (w/v) sodium EDTA for 20 
minutes. The gels were finally washed with Milli-Q water for 3 X 5 minutes and scanned 
on an UMAX ImageScanner for image requisition. The silver stained gels were kept in 
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2.2.8 In-gel Proteolytic Digest 
 
Differentially expressed protein spots were manually excised from the silver 
stained gels and transferred to 96-well polypropylene microtitre plates using a self-made 
plunger. The gel plugs were washed once with 150 µl of wash buffer (2.5 mM ammonium 
bicarbonate, 50% v/v ACN) for 20 minutes before incubation in fresh wash buffer at 4°C 
for at least 24 hours. After incubation, a fresh 150 µl of the same solution was replaced 
and the plate was further incubated with shaking at 37oC for 15 minutes. This was 
repeated twice before the solution was discarded and the gel spots were speed vacuum 
dried for 5 minutes. The gel spots were reduced with 10mM DTT in 100mM sodium 
bicarbonate at 56oC for 1 hour, and then alkylated with 55mM IAA in 100mM sodium 
bicarbonate in the dark at room temperature for 45 minutes.  The IAA/sodium bicarbonate 
solution was then discarded and the gel spots were washed with 100mM ammonium 
bicarbonate at 37oC for 10 minutes with shaking, followed by dehydration with 100% 
acetonitrile for 10 minutes at room temperature. The above wash and dehydration steps 
were repeated once. The spots were finally dried in a Savant Automatic Environmental 
Speed Vac concentrator for 5-10 minutes. 10 µl of trypsin solution (20 µg/µl trypsin; 
Promega Corporation, Madison, WI, USA, 25 mM ammonium bicarbonate) was then 
added to each gel spot and incubated at 4ºC for 30 minutes to allow the gel spots to soak 
up the trypsin solution. Excess trypsin solution was then removed from each well and 10µl 
of 25mM ammonium bicarbonate solution was added. Enzymatic digestion was carried 
out by incubating the gel plugs at 37°C for 16 hours without shaking. Peptides were 
further extracted with sonication in 10 µl of extraction buffer (50% ACN, 0.1% TFA) for 
20 minutes in a sonicator water bath. 
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2.2.9 Mass Spectrometry 
 
2.2.9.1 Matrix-assisted Laser Desorption/Ionization Time of Flight Mass 
Spectrometry (MALDI-TOF-MS) 
Peptides were analyzed on a MALDI-TOF Voyager-DE STR mass spectrometer 
operated on delayed extraction and reflector mode. 1 µl of peptide mixture was 
crystallized with an equal volume of freshly prepared CHCA matrix solution (10 mg/ml) 
in 50% ACN/0.1% TFA solution onto a MALDI target 100-well plate. Spectra were 
acquired manually with laser intensity set at 2400, 50 shots per spectrum and a mass range 
of m/z 700 to m/z 3000. All spectra were calibrated internally using two trypsin autodigest 
ions (m/z 842.51, m/z 2211.104) in Data Explorer software (Applied Biosystems). 
Database search was performed using the MS-FIT software using the follow parameters: 
carbamidomethylation of cysteine, all species, all Mr and pI, four minimum peptide 
required to match, mass tolerance at 50 ppm, methionine oxidation, N-terminus 
acetylation, acrylamide modified cysteine and phosphorylation at serine, threonine and 
tyrosine. The SWISS-PROT non-redundant database was queried first, followed by the 
NCBI database, if no significant protein matches was found.  
 
2.2.9.2 Matrix-assisted Laser Desorption/Ionization Time of Flight/Time of Flight 
Mass Spectrometry (MALDI-TOF/TOF-MS) 
 
Peptides were also analyzed on the Applied Biosystems 4700 Proteomics Analyzer 
(MALDI-TOF/TOF). 0.5 µl of peptide mixtures were spotted on a 192 wells target plate 
and crystallized with equal volume of CHCA matrix solution (5 mg/ml). MS data were 
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automatically acquired with a trypsin auto-digest exclusion list and the five most intense 
ions selected for MS/MS. The collision gas was atmospheric air and the energy was 1 kV. 
Interpretation was carried out using the GPS Explorer software and database searching 
was done using the in-house MASCOT protein identification software searched against 
the Swiss-Prot / TrEMBL and human IPI protein databases. Both combined MS-MS/MS 
and MS/MS only searches were conducted with the following settings: MSDB database, 
all entries, peptide tolerance at 200 ppm, MS/MS tolerance at 0.3 Da, 
carbamidomethylation of cysteine (fixed modification), phosphorylation at serine, 
threonine and tyrosine (variable modifications), methionine oxidation (variable 
modifications), N-terminus acetylation (variable modification) and chlorination at tyrosine 
residues – chlorotyrosine / dichlorotyrosines (variable modification). 
 
2.2.9.3 Nano Liquid Chromatography (LC) -MS/MS system 
 
NanoLC-MS/MS of the digested peptides was performed using a QSTAR-XL 
hybrid quadrupole-time of flight tandem mass spectrometer (Applied Biosystems, Foster 
City, USA) coupled to an UltimateTM nano LC analytical system, LC-Packings (Sunnyvale, 
CA) LC system comprising of a FAMOS autoinjector unit, a SWITCHOS ten port valve 
unit, and an ULTIMATE
PLUS 
nano-flow pumping unit. An injection volume of 7µl from 
each fraction aliquot was made using the FAMOS onto a reversed-phase trapping C-18 
peptide trapping cartridge (300um x 5mm, LC-Packings) in a flow of 0.1% formic acid for 
5 min at 25µl/min. Following the wash step the flow from the ULTIMATE
PLUS 
was 
diverted back through the trapping cartridge at 100nl/min using the SWITCHOS. Peptides 
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were eluted from the cartridge by application of a gradient from 0-90% acetonitrile in 
0.1% formic acid over 40 minutes at 100nl/min, and separated by passing through a 75 µm 
internal diameter x 10 cm length column which was packed in-house with 5µm C-18 
reversed phase packing (Column Engineering, Ontario, CA). Peptides eluting from the 
column were sprayed directly into the orifice of the mass spectrometer, which was run in 




charged ions with 
signal intensity greater than 8 counts per second over the mass range of 300 – 2000 amu. 
For collision induced dissociation (CID), nitrogen gas was used at a setting of 4 and the 
collision energy set to automatic allowing increased energy with increasing ion mass.  
Each fraction that was run was searched against the human IPI protein database 
(EBI, Hinxton, UK) using the MASCOT (Matrix Science, London, UK) search engine. 
From the search results a mass exclusion list was generated for each fraction based on the 
peptide masses of 10 matching peptides or up to a maximum of 2000 masses. These 
masses were then excluded from MS/MS fragmentation when the remaining aliquot of 
each fraction was re-run.  
 
2.2.10 Western Blot & detection for confirmation of differentially regulated proteins 
and to show enrichment of mitochondrial fraction. 
 
Western blot analysis were conducted to confirm the expression of some of the 
differentially proteins detected via DIGE technology, to show the reliability of the 
methodology. Western blotting was also done with protein specific to mitochondria (eg, 
pyruvate dehydrogenase) to show the enrichment of mitochondrial fraction in our 
experiments.  15µg or 30µg of whole cell lysates and 15 µg of mitochondrial proteins, of 
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control and treated HepG2 cells, were added 1:1 to 2X sample loading buffer (120mM 
Tris-Cl  pH6.8, 20% v/v glycerol, 4% w/v SDS, 0.01% w/v bromophenol blue), boiled to 
95°C for 5 minutes, loaded and run on 1-dimensional SDS-PAGE (containing 12%T 
separating, 4%T stacking gel) (Appendix II) at a constant current of 15 mA/gel for ~1.5 
hours in Tris-glycine SDS-PAGE running buffer (0.0025 M Tris, 0.0192 M glycine, 0.01 
% w/v SDS, pH 8.3). The gels after the SDS-PAGE run, were detached from the glass 
plates and incubated in transfer buffer (0.0025 M Tris, 0.0192 M glycine , 0.01 % w/v 
SDS, pH 8.3 and 20% methanol), and incubated with gentle shaking for 5 minutes at room 
temperature. Nitrocellulose membranes & blotting papers trimmed to the size of 8cm by 
6cm were also pre-soaked in transfer buffer for 5 minutes at room temperature. The 
proteins were then transferred onto the nitrocellulose membranes at 100V for 60 minutes, 
using the mini-protean Trans-Blot Cell. A table of the western blotting and detection 
procedures with the antibodies are seen below. 
 




1. Block 2 h with 5 % skimmed milk in PBST with 
gentle shaking. (10 ml) 
2. Wash with PBST, 10 minutes with gentle shaking. 
3. Incubate with mouse anti-mortalin primary antibody, 
1:1000 dilution in 5 ml 1 % skimmed milk in PBST, 
1 h at room temp with gentle shaking. 
4. Wash with PBST with gentle shaking, 3 x 10 min. 
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5. Incubate with Sheep anti-mouse HRP-conjugated 
secondary antibody, 1:5000 dilution in 5 ml 1 % 
skimmed milk in PBST, 1 h at room temp, with 
gentle shaking. 
6. Wash with PBST with gentle shaking, 3 x 10 min. 






1. Block 2 h with 5 % skimmed milk in PBST with 
gentle shaking. (10 ml) 
2. Wash with PBST, 10 minutes with gentle shaking. 
3. Incubate with mouse anti-PDH primary antibody, 
1:500 dilution in 5 ml 1 % skimmed milk in PBST, 1 
h at room temp with gentle shaking. 
4. Wash with PBST with gentle shaking, 3 x 10 min. 
5. Incubate with Sheep anti-mouse HRP-conjugated 
secondary antibody, 1:5000 dilution in 5 ml 1 % 
skimmed milk in PBST, 1 h at room temp, with 
gentle shaking. 
6. Wash with PBST with gentle shaking, 3 x 10 min. 




1. Block 2 h with 5 % skimmed milk in PBST with gentle 
shaking. (10 ml) 
2. Wash with PBST, 10 minutes with gentle shaking. 
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3. Incubate with rabbit anti-actin primary antibody, 1:2000 
dilution in 5 ml 1 % skimmed milk in PBST, 1 h at room 
temp with gentle shaking. 
4. Wash with PBST with gentle shaking, 3 x 10 min. 
5. Incubate with Goat anti-rabbit HRP-conjugated 
secondary antibody, 1:2500 dilution in 5 ml 1 % 
skimmed milk in PBST, 1 h at room temp, with gentle 
shaking. 
6. Wash with PBST with gentle shaking, 3 x 10 min. 








1. Block 2 h with 5 % skimmed milk in PBST with gentle 
shaking. (10 ml) 
2. Wash with PBST, 10 minutes with gentle shaking. 
3. Incubate with rabbit anti-GAPDH primary antibody, 
1:1000 dilution in 5 ml 1 % skimmed milk in PBST, 1 h 
at room temp with gentle shaking. 
4. Wash with PBST with gentle shaking, 3 x 10 min. 
5. Incubate with Goat anti-rabbit HRP-conjugated 
secondary antibody, 1:2500 dilution in 5 ml 1 % 
skimmed milk in PBST, 1 h at room temp, with gentle 
shaking. 
6. Wash with PBST with gentle shaking, 3 x 10 min. 
7. ECL western blotting detection system. 
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Hsp27  
1. Block 2 h with 5 % skimmed milk in PBST with gentle 
shaking. (10 ml) 
2. Wash with PBST, 10 minutes with gentle shaking. 
3. Incubate with rabbit anti-Hsp27 primary antibody, 1:200 
dilution in 5 ml 1 % skimmed milk in PBST, 1 h at room 
temp with gentle shaking. 
4. Wash with PBST with gentle shaking, 3 x 10 min. 
5. Incubate with Goat anti-rabbit HRP-conjugated 
secondary antibody, 1:2500 dilution in 5 ml 1 % 
skimmed milk in PBST, 1 h at room temp, with gentle 
shaking. 
6. Wash with PBST with gentle shaking, 3 x 10 min. 
7. ECL western blotting detection system. 
 
Table 3. Western blot protocols for the proteins of interest. PBST contains 0.1% PBS 
and 0.1% Tween 20. 
 
2.2.11 HOCl Treatment of Delipidated Bovine Serum Albumin (BSA) 
 
10 mg/ml of delipidated BSA in phosphate buffered saline (PBS) was incubated 
with 1mM of HOCl at 37ºC for 1 hour. Excess HOCl was removed via NAP-25 columns, 
which are prepacked disposable columns containing Sephadex® G-25 medium of DNA 
grade for rapid and convenient desalting and buffer exchange of nucleic acids, proteins 
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and oligonucleotides (≥10 mers). 1µg of delipidated BSA and HOCl-treated delipidated 
BSA were then run on one-dimensional SDS-PAGE (refer to section 2.2.10), silver 
stained (section 2.2.7), excised and subjected to in-gel proteolytic digest (section 2.2.8), 


























3 Results  
3.1 Cell Culture Treatment 
 
Cell images of normal HepG2 cells were taken prior to HOCl treatment. The cells 
appeared satellite in nature, anchoring to their neighbouring cells (Figure 5A). In contrast 
the cells after 60µM HOCl treatment appeared rounded and detached from its neighbours 









Figure 5: Cell culture images of HepG2 human hepatoma cell line. (A) Normal cells 
prior to HOCl treatment. (B) Changes in cellular morphology upon 60µM HOCl 
treatment.  
60µM HOCl Treated Normal 
B A 
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3.2 Analysis of the Protein Expression Profile in HepG2 Whole Cell Lysates 
 
3.2.1 2-D DIGE 
Figure 6A and 6B show the representative 2-D DIGE gel images of the control 
versus 30µM HOCl and control versus 60µM HOCl treated whole cell lysate respectively. 
Using the DeCyder image analysis software, more than 2000 spots were detected from 
each gel and each spot was quantitated statistically based on statistical tests such as 
Average ratio, Student’s T-test and One-way ANOVA. As there were no changes in the 
expression profiles of the control and treated samples, differentially expressed protein 
spots were selected and confirmed based on a cutoff limit of ≥ 1.4 fold-difference, with a 
statistical significance of p<0.05, and appearance of ≥80% of the total gel images or of 
≥15 out of 18 spot maps generated. A total of 19 differentially regulated spots were 
detected in the combined datasets of the 30µM and 60µM HOCl treated cells. These are 
represented on the composite 2DE map of HepG2 as shown in Figure 7. Of the 19, 1 was 
found to be upregulated in cells exposed to 30µM HOCl, 4 were upregulated and 13 were 
downregulated in cells exposed to 60µM treatment, and 1 protein was upregulated in both 
instances. The majority of proteins were downregulated in the treated samples with at 
60µM of HOCl treatment (Table 4). Presently, 13 of the 19 protein spots have been 
successfully identified by MALDI TOF-TOF MS/MSMS & ESI-MS/MSMS (Table 5).  
Figure 8 shows the (I) 2D-DIGE spot image and the (II) biological variation 
analysis (BVA) presentation of protein spot 1103 identified as biliverdin reductase A 
precursor, as detected using the DeCyder image analysis software. The graphical plot (E) 
of the standardized log abundance ratio of the protein spot in each sample allowed us to 
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perceive the trend in the protein expression of a particular protein spot upon treatment of 
the cells with increasing dosage of the HOCl treatment. 3-D view (D) of the protein spot 
represented allowed a clearer visualization of the differential expression volume of the 
protein spot which is sometimes hard to determine in normal gel image view (C). In this 
case, spot 1103 was seen to be downregulated only at higher treatment dosage of 60µM 
HOCl. The protein was significantly downregulated by -2.03 folds in HOCl treated cells 
with p<0.05 (1.9e-007) as seen in the protein table view (F). 
Of the 19 proteins found differentially expressed, 4 of them (3 upregulated and 1 
downregulated) were not detected by the Decyder software, although they were seen both 
on the DIGE labeled and corresponding silver-stained gels to be differentially regulated 


































































































































































































































































































































































































Figure 7: 2-DE map of the HepG2 liver whole cell lysate. A total of 19 differentially 
expressed protein spots were differentially regulated upon HOCl treatment. Protein spots 
circled in orange indicates spots that are upregulated in both concentrations of HOCl 
treatment (1 spot). Purple indicates spots upregulated in 30µM HOCl treated only (1 
spot). Red indicates spots upregulated in 60µM HOCl treated only (4 spots), and green 








































Control vs 30µM HOCl Control vs 60µM HOCl 
I.
BA
Figure 8: Spot 1103. [I] 2-D DIGE image of (A) control vs 30µM HOCl-treated (B) control 
vs 60µM HOCl-treated HepG2 cell lysate. [II] Biological variance analysis (BVA) 
presentation of the spot detected using the DeCyder software. (C) Shows spot images of the 
control vs treated samples. (D) 3-D view of the protein spot represented. (E) Graphical view 
of the standardized log abundance ratio of the protein spot in each sample. (F) Protein table 








Table 4: List of protein spots that are differentially expressed and data generated 
from the DeCyder software. Spot No. refers to the numbers assigned to protein spots 
generated by the software. Appearance refers to the percentage of the gel images or spot 
maps containing the protein spot, a 100% (18/18) means that the spot is consistently 
present in all gels. T-Test refers to Student’s T-Test p value. Av. Ratio refers to the 
average ratio of the protein spots, a positive number mean up-regulation and a negative 
number means down-regulation with HOCl treatment. App Mr and App pI refer to 
apparent molecular weight and apparent pI values respectively, estimated using an in-
house software. Mr is in Da. 
 
 
Differentially Exp. Spot 
No. 30µM 60µM Both Appearance T-test 
Av. 
Ratio App Mr App pI 
477  √  100% (18/18) 0.00014 1.44 85,625 5.55 
835  √  100% (18/18) 0.00018 -1.64 57,090 5.89 
919  √  100% (18/18) 3.3e-009 -2.04 51,363 6.03 
1103  √  100% (18/18) 1.9e-007 -2.03 43,111 6.24 
1225  √  100% (18/18) 9.8e-005 -2.02 39,666 6.23 
1259  √  100% (18/18) 0.0034 -1.86 39,888 7.54 
1332  √  100% (18/18) 0.0038 -1.91 37,888 5.98 
1426  √  83.33% (15/18) 0.0015 -1.61 35,888 7.65 
1665   √ 100% (18/18) 4.4e-006 1.52 29,895 6.16 
1709  √  100% (18/18) 4.4e-006 -1.64 29,527 6.55 
1787 √   100% (18/18) 0.00046 1.43 27,833 6.52 
1814  √  100% (18/18) 2.5e-005 -1.45 27,317 8.19 
1867  √  100% (18/18) 2.3e-009 -2.84 24,887 6.51 
2038  √  100% (18/18) 5.1e-007 -1.69 22,457 6.26 
2109  √  100% (18/18) 5.5e-005 -2.63 20,542 6.33 
835L*  √  50% (9/18) NA ++ 54,843 5.86 
919U*  √  50% (9/18) NA +++++ 52,318 6.03 
R*  √  50% (9/18) NA +++ 27,906 7.27 














* Protein spots that are found to be present only in 60µM HOCl treated samples but 
not detected by the Decyder Image analysis software.  
** Protein spot that is found to be downregulated in 60µM HOCl treated samples but 
not detected by the Decyder Image analysis software.  
+ represents the level of upregulation. 
- represents the level of downregulation. 









































Figure 9: List of protein spots that are differentially expressed but not detected 
by the DeCyder software. A. Spot 835 is downregulated upon treatment and 835L is 
seen to appear only in the treated. B. Spot 919 is downregulated upon treatment and 
919U is found present only in treated. C. Spot G is found to be downregulated upon 
treatment and spot R is seen present only in treated.  













DIGE Control 60µM HOCl Treated
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3.2.2 MS Identification of Protein Spots 
 
To identify the differentially expressed and carbonylated protein spots from silver-
stained gels, the spots were excised from the gels for in-gel digestion followed by MS.  
Majority of the spots were amenable to mass spectrometric identification.  However, spots 
that were faint and small were excised from preparative gels of higher protein loads, to 
obtain enough proteins for analysis. Figure 10 shows a representative MALDI-TOF/TOF 
MS peptide mass spectrum of Stress-70 protein, mitochondrial precursor (GRP 75 / 
Mortalin) subjected to trypsin digest.  Trypsin cleaves specifically after arginine and 
lysine residues and generates small peptides that can be eluted from gel matrices.  Figure 
11 shows the result of database search of the tryptic peptide mass fingerprint (PMF) of this 
protein.  Figures 12 and 13 show the protein view and the peptide view of one of the 
sequences peptides, AQFEGIVTDLIR respectively. In addition, protein spots that yielded 














































































































































































































































































































Figure 11: MASCOT search result of spot 477. Result of Mascot database search 
of tryptic peptide mass fingerprint (PMF) of Stress-70 protein, mitochondrial 









Figure 12: Protein view of the Mascot database search result of Stress-70 protein, 
mitochondrial precursor (GRP 75 / Mortalin). The matched peptides and sequence 
coverage is shown, with the matched ion scores of sequenced peptides. 
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 Figure 13: Peptide view of the MS/MS fragmentation of peptide 
AQFEGIVTDLIR of Stress-70 protein, mitochondrial precursor (GRP 75 / 
Mortalin). This peptide is one of the three matched peptides that were sequenced. 
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Table 5: List of identified proteins that are differentially expressed in HOCl treated 
HepG2 whole cell lysate. The proteins are catalogued according to their differential 
expression profile. 13 out of 19 differentially expressed protein spots were identified. 
Protein spots not identified - 1225, 1426, 1709, 1814, 1867 & 2109. SCL indicates the 
subcellular location of the proteins. N: nucleus, C: cytoplasm, MT: mitochondria, PM: 




















Involved in redox regulation of 
the cell. Protects radical-sensitive 
enzymes from oxidative damage 
by a radical-generating system. 
Acts synergistically with 
MAP3K13 to regulate the 
activation of NF-kappa-B in the 
cytosol. Catalytic activity: 2 R'-
SH + ROOH = R'-S-S-R' + H2O + 
ROH.  
Subunit: Homodimer; disulfide-
linked, upon oxidation (By 










II) Proteins upregulated in  30µM  HOCl treatment 
1787 Q96DE0 
NUDT16 protein , 
Nucleoside 
diphosphate-linked 
moiety X motif 16 
Probably mediates the hydrolysis 
of some nucleoside diphosphate 
derivatives. Cofactor: Manganese 
or magnesium. 
- 21,273 / 6.38 
27,833 / 
6.52 




precursor (75 kDa 
glucose regulated 
protein) (GRP 75) 
(Peptide-binding 
protein 74)(Mortalin) 
Implicated in the control of 
cell proliferation and cellular 
aging. May also act as a 
chaperone. 





subfamily A member 




restoration gene 3 
protein) 
 
Co-chaperone of Hsc70.  










Belongs to the zinc-containing 
alcohol dehydrogenase family. 
Quinone oxidoreductase 
subfamily. 








Binds ATP, opioids and 
phosphatidylethanolamine. 
Has lower affinity for 
phosphatidylinositol and 
phosphatidylcholine. Serine 
protease inhibitor which 
inhibits thrombin, neuropsin 
and chymotrypsin but not 
trypsin, tissue type 
plasminogen activator and 
elastase  
Subunit: Interacts with Raf-1 
and seems to inhibit it. 
C 20,925 / 7.43 
27,906 / 
7.27 
IV) Proteins downregulated in 60µM HOCl treatment 
835 O60884 
DnaJ homolog 
subfamily A member 




restoration gene 3 
protein) 
Co-chaperone of Hsc70.  
SUBUNIT: Interacts with 
HIRA. 




Solute carrier family 
25 member 24, 
isoform 1 
[Solute carrier family 
25 (Mitochondrial 
carrier\; phosphate 
carrier), member 24 / 
Small calcium-
binding mitochondrial 
carrier 1 ] 
Calcium-dependent 
mitochondrial aspartate and 
glutamate carrier. May have a 
function in the urea cycle 









glyceraldehyde 3-phosphate + 
phosphate + NAD+ = 3-
phospho-D-glyceroyl 
phosphate + NADH.  
Pathway: Second phase of 
glycolysis; first step. 




1103 P53004 Biliverdin reductase A precursor 
Reduces the gamma-methene 
bridge of the open tetrapyrrole, 
biliverdin IX alpha, to 
bilirubin with the concomitant 
oxidation of a NADH or 
NADPH cofactor.  
Catalytic activity: Bilirubin + 
NAD(P)+ = biliverdin + 
NAD(P)H.  
Cofactor: Binds 1 zinc ion per 
subunit.  Cofactor: NADH or 
NADPH. Has dual pH/cofactor 
(NADH, NADPH) specificity: 
uses NADH at the acidic pH 
range (6-6.7) and NADPH at 
the alkaline range (8.5-8.7).  
Pathway: Heme metabolism; 
first step. Tissue specificity: 
Liver. 








Catalytic activity: Agmatine + 




Tissue Specificity: Highly 
expressed in liver and kidney. 
Also found in skeletal muscle, 
fetal liver, brain, testis, skin 
and the gastrointestinal tract. 








Controls reversibly actin 
polymerization and 
depolymerization in a pH-
sensitive manner. It has the 
ability to bind G- and F-actin 
in a 1:1 ratio of cofilin to actin. 
It is the major component of 
intranuclear and cytoplasmic 
actin rods. 
Tissue Specificity: Widely 
distributed in various tissues. 
N/C 18,588 / 8.26 
22,457 / 
6.26 
G P00374 Dihydrofolate reductase, DHFR 
Catalytic activity: 5,6,7,8-
tetrahydrofolate + NADP+ = 






and 4-aminobenzoate: step 3 
[final step]. Reaction catalyzed 
by this enzyme represents an 
essential step for de novo 
glycine and purine synthesis, 
DNA precursor synthesis, and 
for the conversion of dUMP to 
dTMP. 




3.2.3 Detection of Oxidized / Carbonylated Proteins 
 
Using DIGE analysis, we can only detect proteins that are differentially regulated 
upon HOCl treatment. As protein modifications can result in change of protein functions, 
we are interested to elucidate which are the proteins that are modified during HOCl-
induced oxidative stress. Thus, we decided to look into the proteins that are oxidized / 
carbonylated by HOCl in HepG2 cells.   
Protein carbonyls are irreversible protein modifications of HOCl-mediated 
oxidation that are introduced by various mechanisms at different sites of proteins. It can be 
used as a biomarker to illuminate the extent of HOCl-induced oxidative stress on cells. 
Therefore, we decided to detect the carbonylated proteins in HOCl-treated HepG2 cells by 
derivitizing the carbonyls with 2.4-dinitrophenylhydrazine (DNPH), which can be 
detected via western blotting probed with anti-DNP antibodies. 
From our results, we showed that when the cells were treated with increasing 
concentration of HOCl, the number of oxidized proteins increased drastically (Figure 14). 
A total of 113 protein spots were found to be oxidized / carbonylated upon HOCl 
treatment. 17 of these spots were found to exhibit basal levels of oxidation in the control 
sample. Of these, 10 showed increased oxidation in both concentrations of HOCl 
treatment, and 7 were shown to have increased oxidation in 60µM HOCl treated samples 
only. 23 spots were found oxidized at both concentrations of HOCl treatment, with more 
intense oxidation in 60µM of HOCl treated sample. Lastly, 73 spots were found to be 
oxidized in 60µM HOCl treated sample only. The immunoreactive spots were excised 
from silver stained gels (see Figure 15) for protein identification via mass spectrometry. 
104 of these protein spots have been successfully identified by MALDI TOF-TOF 
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MS/MSMS & ESI-MS/MSMS. Of these, 61 unique proteins have been identified. Many 
of the protein spots that appear in trails are found to be isoforms of a single protein. The 













































































































































































































































































































































































Figure 15: Silver stained gel of HepG2 cell lysate with the immunoreactive 
oxidized spots annotated. Blue indicates spots with basal oxidation that increases in 
both treatment conditions. Pink indicates spots with basal oxidation that increases in 
60µM HOCl treated cells. Green indicates spots that were oxidized in both treated 
samples. Red indicates spots that were oxidized in 60µM HOCl treatment only. 
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Table 6: List of 61 unique proteins identified that are oxidized / carbonylated 
proteins in HOCl treated HepG2 whole cell lysate. The proteins are catalogued 
according to their oxidation profile. 104 out of 113 protein spots that are oxidized were 
identified. Protein spots not identified – 27, 29, 30, 48, 68, 106, 111 & 112. SCL indicates 
the subcellular location of the proteins. N: nucleus, C: cytoplasm, MT: mitochondria, PM: 


















Q99497 Protein DJ-1 (Oncogene DJ1) 
Acts as positive regulator of androgen 
receptor-dependent transcription. May 
function as redox-sensitive chaperone 
and as sensor for oxidative stress. 
Prevents aggregation of SNCA. 
Protects neurons against oxidative 
stress and cell death. Plays a role in 
fertilization. Has no proteolytic 
activity. Has weak transforming 
activity. 












Essential for the import of protein 


















Actins are highly conserved proteins 
that are involved in various types of 
cell motility and are ubiquitously 
expressed in all eukaryotic cells. 





























- alpha & 
  
- beta chains 
Tubulin is the major constituent of 
microtubules. It binds two moles of 
GTP, one at an exchangeable site on 
the beta chain and one at a 































Keratin, type II  
 
- cytoskeletal 7 / 
Sarcolectin 
 
- cytoskeletal 8 
Heterotetramer of two type I and two 
type II keratins 
cytoskeletal and microfibrillar keratin
































Implicated in the control of cell 
proliferation and cellular aging. May 
also act as a chaperone. 



















Catalytic activity: A phosphate 
monoester + H2O = an alcohol + 
phosphate.  
Cofactor: Binds 1 magnesium ion 
/ Binds 2 zinc ions. 









II) Proteins with basal oxidation and increasingly oxidized in 60µM HOCl treatment only 
5 P37837 Transaldolase 
Transaldolase is important for the 
balance of metabolites in the pentose-
phosphate pathway. 















Keratin, type I 
cytoskeletal 18 
(Cytokeratin 18) 
Heterotetramer of two type I and two 
type II keratins. Keratin 18 associates 
with keratin 8. Defects in KRT18 are 
a cause of cryptogenic cirrhosis 


















21 P12277 Creatine kinase B 
Reversibly catalyzes the transfer of 
phosphate between ATP and various 
phosphogens (e.g. creatine 
phosphate). Catalytic activity: ATP + 
creatine = ADP + phosphocreatine. 














Multifunctional enzyme that, as well 
as its role in glycolysis, plays a part in 
various processes such as growth 
control, hypoxia tolerance and allergic 
responses. May also function in the 
intravascular and pericellular 
fibrinolytic system due to its ability to 
serve as a receptor and activator of 
plasminogen on the cell surface of 
several cell-types such as leukocytes 
and neurones. 
MBP1, an isoform produced by 
alternative initiation binds to the c-
myc promoter and acts as a 
transcriptional repressor. May be a 
tumor suppressor. 
















binding protein ) 
Single-stranded nucleic acid 
binding protein that binds 
preferentially to oligo dC. 








protein which promotes membrane 
fusion and is involved in 
exocytosis. 







Probably plays a role in anchoring 
the complex to other cellular 
components. 








Implicated in mitochondrial protein 
import and macromolecular 
assembly. May facilitate the correct 
folding of imported proteins. May 
also prevent misfolding and 
promote the refolding and proper 
assembly of unfolded polypeptides 
generated under stress conditions in 
the mitochondrial matrix. 






P20700 Lamin B1 
Components of the nuclear lamina, 
a fibrous layer on the nucleoplasmic 
side of the inner nuclear membrane, 
which is thought to provide a 
framework for the nuclear envelope 
and may also interact with 
chromatin. 










78) (ER lumenal 
Ca(2+) binding 
protein grp78). 
Probably plays a role in facilitating 
the assembly of multimeric protein 
complexes inside the ER. 





cognate 71 kDa 
protein 
Chaperone. Isoform 2 may function 
as an endogenous inhibitory 
regulator of HSC70 by competing 
the cochaperones. 








Heat shock 70 
kDa protein 1 
(HSP70.1) 
In cooperation with other 
chaperones, it stabilizes preexistent 
proteins against aggregation & 
mediate folding of newly translated 
polypeptides in cytosol & within 
organelles.  


































May play a role in the regulation of 
both apoptosis and cell 
proliferation. 


























 – Progerin 
Lamins are components of the 
nuclear lamina, a fibrous layer on 
the nucleoplasmic side of the inner 
nuclear membrane, which is 
thought to provide a framework for 
the nuclear envelope and may also 
interact with chromatin. 

































L isoform a 
(hnRNP L) 
a component of the heterogenous 
nuclear ribonucleoprotein (hnRNP) 
complexes which provide the 
substrate for the processing events 
that pre-mRNAs undergo before 
becoming functional, translatable 
mRNAs in the cytoplasm. 













protein 2) (1-Cys 
peroxiredoxin) 
Involved in redox regulation of the 
cell. Can reduce H2O2 and short 
chain organic, fatty acid, and 
phospholipid hydroperoxides. May 
play a role in the regulation of 
phospholipid turnover as well as in 
protection against oxidative injury. 
Catalytic activity: Donor + H2O2 = 
oxidized donor + 2 H2O. 











May have nucleic acid binding 
capability that may participate in 
important transcriptional or 
translational control of cell growth, 
metabolism and carcinogenesis.   







Catalyzes the NADPH-dependent 
reduction of a wide variety of 
carbonyl-containing compounds to 
their corresponding alcohols with a 
broad range of catalytic 
efficiencies.  
Catalytic activity: Alditol + 
NAD(P)+ = aldose + NAD(P)H. 










PPIases accelerate the folding of 
proteins. It catalyzes the cis-trans 
isomerization of proline imidic 
peptide bonds in oligopeptides.   
 








Associated with nucleolar 
ribonucleoprotein structures and 
bind single-stranded nucleic acids. 
It may function in the assembly 
and/or transport of ribosome. 










C1/C2 (hnRNP C1 
/ C2) 
May play a role in ribonucleosome 
assembly by neutralizing basic 
proteins such as a and B core 
hnRNP. 








family 25 member 






24 / Small 
calcium-binding 
mitochondrial 
carrier 1 ] 
Calcium-dependent mitochondrial 
aspartate and glutamate carrier. 
May have a function in the urea 
cycle 










a competitive inhibitor of S- 
adenosyl-L-methionine-dependent 
methyl transferase reactions; 
therefore may play a key role in the 
control of methylations via 




homocysteine + H(2)O = L- 
homocysteine + adenosine. 
Cofactor: Binds 1 NAD per subunit.



















protein 48)  
 















2. Catalyzes the formation of S-
adenosylmethionine from 
methionine and ATP. Catalytic 
activity: ATP + L-methionine + 




























39 P08670 Vimentin 
class-III intermediate filaments 
found in various non-epithelial 
cells, especially mesenchymal cells.
- 53,545 / 5.06 
63,136 
/ 5.05









H (hnRNP H) 
a component of the heterogenous 
nuclear ribonucleoprotein (hnRNP) 
complexes which provide the 
substrate for the processing events 
that pre-mRNAs undergo before 
becoming functional, translatable 
mRNAs in the cytoplasm. Binds 
poly(RG). 











Cleaves presequences (transit 
peptides) from mitochondrial 
protein precursors (By similarity). 
Catalytic activity: Release of N-
terminal transit peptides from 
precursor proteins imported into the 
mitochondrion, typically with Arg 
in position P2. 





1, beta subunit 
(TCP-1-beta) 
(CCT-beta) 
Molecular chaperone; assist the 
folding of proteins upon ATP 
hydrolysis. Known to play a role, in 
vitro, in the folding of actin and 
tubulin. 










Seems to exhibit multiple functions 
depending on this nuclear or 
cytosolic presence. Has single-
stranded DNA-stimulated ATPase 
and ATP-dependent DNA helicase 
(3' to 5') activity suggesting a role 
in nuclear processes such as 
recombination and transcription. Is 
a essential cofactor in the c-Myc 
oncogenic transformation. 
Stimulates gene activation mediated 
by beta- catenin and T-cell factor 
(TCF) complex. Could represent a 
class of cofactors recruited by 
transcriptional activation domain 
that function in diverse pathways 








Catalytic activity: Thioredoxin + 
NADP+ = thioredoxin disulfide + 
NADPH. Cofactor: Binds 1 FAD 
per subunit. The active site is a 
redox-active disulfide bond. 















Key enzyme for ketone body 
catabolism. Transfers the CoA 
moiety from succinate to 
acetoacetate. Formation of the 
enzyme-CoA intermediate proceeds 
via an unstable anhydride species 
formed between the carboxylate 
groups of the enzyme and substrate. 
Catalytic activity: Succinyl-CoA + 
a 3-oxo acid = succinate + a 3-
oxoacyl-CoA. 














Plays a role in DNA double-strand 
break (DSB) repair. Binds double-
stranded DNA in a sequence-
nonspecific manner. Acts as a 
structural component of the nuclear 
framework. May also serve as a 
support for spliceosome binding 
and activity. 





















One of the major pre-mRNA-
binding proteins. Binds tenaciously 
to poly(C) sequences. Likely to 
play a role in the nuclear 
metabolism of hnRNAs, 
particularly for pre-mRNAs that 
contain cytidine-rich sequences. 
Can also bind poly(C) single- 
stranded DNA. 
















Heat shock protein 
HSP 90-beta (HSP 
84) (HSP 90) 














Molecular chaperone that functions 
in the processing and transport of 
secreted proteins. 




77 P13797 T-plastin 
Actin-bundling protein found in 
intestinal microvilli, hair cell 
stereocilia, and fibroblast filopodia.




Heat shock 70 
kDa protein 4L 
(Osmotic stress 
protein 94) (Heat 
shock 70-related 
protein APG-1) 
Possesses chaperone activity in 
vitro where it inhibits aggregation 
of citrate synthase 












Forms hydroxylysine residues in -
Xaa-Lys-Gly- sequences in 
collagens. These hydroxylysines 
serve as sites of attachment  for 
carbohydrate units and are essential 
for the stability of the 
intermolecular collagen crosslinks. 
Catalytic activity: Procollagen L-
lysine + 2-oxoglutarate + O(2) = 
procollagen 5-hydroxy-L-lysine + 
succinate + CO(2). 










promotes the GTP-dependent 
translocation of the nascent protein 
chain from the A-site to the P-site 
of the ribosome. Belongs to the 
GTP-binding elongation factor 
family. EF-G/EF-2 subfamily. 








Acts as a factor that allows the 
DNA to undergo a single round of 
replication per cell cycle. Required 
for DNA replication and cell 
proliferation. 














Probably involved in connections of 
major cytoskeletal structures to the 
plasma membrane 
















type 1 receptor 
associated protein)
Chaperone that expresses an 
ATPase activity. 
Subunit: Binds to the intracellular 
domain of tumor necrosis factor 
type 1 receptor. Binds to RB1. 













Provides the precursors necessary 
for DNA synthesis. Catalytic 
activity: 2'-deoxyribonucleoside 
diphosphate + thioredoxin disulfide 
+ H(2)O = ribonucleoside 
diphosphate + thioredoxin. Enzyme 
regulation: Under complex 
allosteric control mediated by the 
binding of deoxynucleoside 
triphosphates and ATP to binding 
sites on the M1 subunit. Pathway: 
DNA replication pathway; first 
step. 















May play a role in regulating the 

















Probably required during 
hematopoiesis to mediate 
antiapoptotic effects of various 
cytokines. Confers resistance to 
apoptosis when overexpressed 
C 33,582 / 5.44 
43,777 
/ 5.37











Acts as a regulatory subunit of the 
26S proteasome which is involved 
in the ATP-dependent degradation 
of ubiquitinated proteins.   







bind in a Ca(2+)-independent 
manner to the fast growing ends of 
actin filaments (barbed end) thereby 
blocking the exchange of subunits 
at these ends. Unlike other capping 
proteins (such as gelsolin and 
severin), these proteins do not sever 
actin filaments.   








a component of the heterogenous 
nuclear ribonucleoprotein (hnRNP) 
complexes which provide the 
substrate for the processing events 
that pre-mRNAs undergo before 
becoming functional, translatable 
mRNAs in the cytoplasm. Probably 
binds G- rich sequences in pre-
mRNAs. 






3.3 Analysis of the Protein Expression Profile in HepG2 enriched - mitochondrial 
fraction. 
 
As one-third and one-fifth of the differentially regulated and oxidized proteins 
were identified to be mitochondrial proteins (seen in Tables 5 and 6), we decided to delve 
deeper into the mitochondrial proteome to uncover more proteins that might be involved 
in HOCl – mediated cell stress in the mitochondria.  
A recent finding that HOCl caused mitochondrial dysfunction and apoptosis on 
human hepatoma HepG2 and human fetal liver cells (Whiteman et al., 2005) gave further 
weight to the rationale of this experiment.  
Subcellular fractionation can also help to enrich for mitochondrial proteins which 
are usually of low abundance in whole cell protein extracts. With the enriched 
mitochondrial fraction, we performed 2D-DIGE (section 3.3.2) and oxidation / 
carbonylation western detection (section 3.3.3) with an aim to elucidate specifically in the 











3.3.1 Western blotting with anti-pyruvate dehydrogenase (PDH) E1α subunit 
antibody to show enrichment of mitochondrial fraction. 
 
To verify enrichment of the mitochondrial fraction, western blotting using 
antibody against pyruvate dehydrogenase (PDH) E1α subunit, which is found 



































Whole cell lysate 
Figure 16: Western blot showing enrichment of mitochondrial fraction from 
the HepG2 cell line. Pyruvate dehydrogenase (PDH) E1α subunit which is 
localized in the mitochondrion is seen to be highly expressed in the enriched 
mitochondrial fraction as compared to low levels in the whole cell lysate. 
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3.3.2 2D-DIGE analysis 
 
After we had ascertained the enrichment and purity of our mitochondrial 
preparation, we then proceeded to perform 2D-DIGE analysis on the mitochondrial 
proteome of control and 60µM HOCl treated cells. The 2D-DIGE image can be seen in 
Figure 17. 
Figure 18 shows the silver-stained 2D gel image of the mitochondrial proteome of 
HepG2 cells with the differentially expressed protein spots annotated. A total of 39 spots 
were found differentially regulated with 60µM HOCl treatment, 27 were upregulated and 
































Figure 17: 2D-DIGE image of enriched HepG2 mitochondrial fraction. 
Control versus 60µM HOCl treated HepG2 enriched mitochondrial protein profile. 
Proteins from control cells were labeled with Cy3 (green) whereas proteins from 
60µM HOCL treated cells were labeled with Cy5 (red). Yellow spots represent 
proteins of equal quantity in both control and treated samples. Green spots 
represent proteins downregulated with HOCl treatment, and red spots represent 
proteins upregulated with HOCl treatment. The images were captured using the 















































Figure 18: 2-DE silver-stained map of the HepG2 cells enriched 
mitochondrial proteins with the differentially expressed protein spots 
annotated. Protein spots in red indicates spots that are upregulated or present only 











3.0 PI 10.0 
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Table 7: List of protein spots that were differentially expressed in the mitochondria 
proteome. There were 39 protein spots differentially expressed in the mitochondrial fraction 
of 60µM HOCl treated cells. 12 protein spots were found downregulated in treated sample 
while 20 were found upregulated. 7 protein spots were found present only in the treated 
sample. 
Spot No. Appearance T-test Av. Ratio App Mr App pI 
324 100% (12/12) 2.9e-007 -1.50 79,545 5.71 
560 100% (12/12) 0.0059 -1.41 53,076 6.25 
619 100% (12/12) 0.046 -1.56 47,907 6.16 
650 100% (12/12) 0.0011 -1.48 46,615 6.23 
660 100% (12/12) 0.00098 -1.56 45,969 6.08 
681 100% (12/12) 0.00014 -1.84 44,569 6.15 
690 83.33% (10/12) 0.027 -2.34 44,784 5.78 
786 100% (12/12) 0.16 -1.46 41,015 6.45 
944 100% (12/12) 0.022 -2.00 33,261 5.49 
1126 100% (12/12) 0.0055 -2.04 18,306 5.25 
628 100% (12/12) NA - 47,907 5.59 
**F 100% (12/12) NA --- 49,200 6.47 
498 100% (12/12) 0.0018 1.57 58,892 5.24 
499 100% (12/12) 0.016 1.61 58,569 5.30 
500 100% (12/12) 0.021 1.48 58,569 5.48 
508 100% (12/12) 0.0039 1.67 58,892 5.41 
577 100% (12/12) 0.0019 1.83 52,753 6.16 
582 100% (12/12) 0.006 1.55 51,784 4.57 
588 100% (12/12) 0.0086 1.48 51,784 5.92 
599 100% (12/12) 0.00051 2.74 48,553 6.20 
600 83.33% (10/12) 0.012 2.14 49,200 6.43 
604 100% (12/12) 1.40e-05 3.26 49,846 5.79 
613 83.33% (10/12) 0.015 2.43 49,523 5.59 
773 100% (12/12) 0.00048 2.04 41,876 6.09 
835 100% (12/12) 0.0031 1.70 39,076 4.54 
1034 100% (12/12) 0.021 1.86 28,952 6.44 
1042 100% (12/12) 3.50e-07 3.25 28,543 6.33 
1080 100% (12/12) 0.013 2.25 26,577 7.12 
1087 100% (12/12) 0.00064 2.08 23,711 6.43 
1093 100% (12/12) 0.016 1.46 22,974 6.33 
1120 100% (12/12) 0.050 1.53 22,974 5.24 
**954u 50% (6/12) NA + 36,492 6.22 
*641u 50% (6/12) NA ++ 49,523 5.46 
*647u 50% (6/12) NA ++ 49,523 5.97 
*619u 50% (6/12) NA ++++ 49,523 6.15 
*786L 50% (6/12) NA + 41,015 6.43 
*D 50% (6/12) NA ++ 53,076 5.96 
*E 50% (6/12) NA +++ 53,076 5.75 
*G 50% (6/12) NA + 40,907 6.53 
 * Protein spots that are found to be present only in 60µM HOCl treated samples but not detected by the 
Decyder Image analysis software.  
** Protein spot that is found to be upregulated (954u) or downregulated (F) in 60µM HOCl treated 
samples but not detected by the Decyder Image analysis software.  
+ represents the level of upregulation. 
- represents the level of downregulation. 
NA – Not applicable
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Table 8: List of identified proteins that are differentially expressed in the enriched 
mitochondrial fraction of HOCl treated HepG2 cells. The proteins are catalogued 
according to their differential expression profile. 11 out of 39 differentially expressed 
protein spots were identified. SCL indicates the subcellular location of the proteins. N: 













I) Proteins downregulated in 60µM HOCl treatment 








944 P35232 Prohibitin 
Inhibits DNA synthesis. It has a 
role in regulating proliferation. As 
yet it is unclear if the protein or 
the mRNA exhibits this effect. 
May play a role in regulating 
mitochondrial respiration activity 
and in aging. 
MT 29,804 / 5.57 
33,261 / 
5.49 









Keratin, type II 
cytoskeletal 8  
Cytokeratin-8 / CK-8 
/ Keraton-8 / K8 



















PMPCB / MPPB 
Cleaves presequences (transit 
peptides) from mitochondrial 
protein precursors. Catalytic 
activity: Release of N-terminal 
transit peptides from precursor 
proteins imported into the 
mitochondrion, typically with Arg 
in position P2.  Cofactor: Binds 1 
zinc ion per subunit. Subunit: 
Heterodimer of alpha and beta 
subunits 




Similar to Guanylate 
kinase (GMP kinase) 
/ Guanylate kinase 1 
Essential for recycling GMP 
and indirectly, cGMP.  
Catalytic activity: ATP + GMP 
= ADP + GDP. 













carrier family 37 
member 4). 






954u P53701 Cytochrome c-type heme lyase 
Links covalently the heme 
group to the apoprotein of 
cytochrome c. Catalytic 
activity: Holocytochrome c = 
apocytochrome c + heme.   






















3.3.3 Detection of Oxidized / Carbonylated Proteins 
 
In addition, we were also interested in identifying proteins that were found 
to be oxidized in the mitochondria upon 60µM HOCl treatment. We thus 
performed western blot analysis with anti-DNP antibodies to detect derivitized 
carbonylated proteins. The results are shown in Figure 19. 15 out of 29 protein 
spots that were found to be oxidized upon 60µM HOCl treatment were 


























































































































































































































































































































































Table 9: List of 9 unique proteins identified that are oxidized / carbonylated proteins 
in the enriched mitochondrial fraction of HOCl treated HepG2 cells. The proteins are 
catalogued according to their oxidation profile. 15 out of 29 protein spots that either 
increase or decrease in oxidation upon treatment or only oxidized in treated were 
identified. SCL indicates the subcellular location of the proteins. N: nucleus, C: cytoplasm, 












I) Proteins with basal oxidation and increasingly oxidized in 60µM HOCl treatment only 
21 Q15365 
Poly(rC)-binding 
protein 1, Alpha-CP1 
/ hnRNP-E1, Nucleic 
acid-binding protein 
Single-stranded nucleic acid 
binding protein that binds 
preferentially to oligo dC 







D-fructose 1,6-bisphosphate = 
glycerone phosphate + D-
glyceraldehyde 3-phosphate.   
Pathway: Carbohydrate 
degradation; glycolysis; D-
glyceraldehyde 3- phosphate and 
glycerone phosphate from D-
glucose: step 4.   

















channel protein 2 
(VDAC-2 / 
hVDAC2 / Outer 
mitochondrial 
membrane protein 
porin 2 ) 
Forms a channel through the 
mitochondrial outer membrane 
that allows diffusion of small 
hydrophilic molecules. The 
channel adopts an open 
conformation at low or zero 
membrane potential and a closed 
conformation at potentials above 
30-40 mV. The open state has a 
weak anion selectivity whereas the 
closed state is cation-selective. 




















membrane protein  
Mitofilin / p87/89 / 
Proliferation-
inducing gene 4 
protein 




















Elongation factor G 
1, mitochondrial 
precursor 
promotes the GTP-dependent 
translocation of the nascent 
protein chain from the A-site to 
the P-site of the ribosome. 




Solute carrier family 
25 member 24, 
isoform 1 
Calcium-dependent 
mitochondrial aspartate and 
glutamate carrier. May have a 
function in the urea cycle 
MT 53,338 / 6.00 
47,907 / 
5.74 





954u P53701 Cytochrome c-type heme lyase 
Links covalently the heme 
group to the apoprotein of 
cytochrome c. Catalytic 
activity: Holocytochrome c = 
apocytochrome c + heme.   








3.4 Confirmation of Differential Expression of Proteins via Western Blotting –
validation of DIGE 
 
To validate the results we obtained using DIGE analysis, we selected two 
of the proteins from the list of differentially regulated proteins to confirm their 
expression level via western blotting.  
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) which was found 
downregulated in 60µM HOCl treated cells (spot 1259, see Figure 7 and Table 5), 
was detected in whole cell lysates using anti-GAPDH antibodies.  As shown in 
Figure 20A, GAPDH was seen to be of same expression level in the control and 
30µM HOCl treated cells, but reduced in 60µM HOCl treatment. This confirmed 
the results we have obtained using DIGE.  
Grp75 / Mortalin which was found to be upregulated in 60µM HOCl 
treated cells (spot 477, Figure7 and Table 5), was also confirmed with results 
shown in Figure 20B. The control and 30µM HOCl treated samples showed no 



























































Figure 20: Western blotting to validate the differential expression of 2 proteins 
that are detected using DIGE. A) GAPDH (spot no. 1259) is shown 
downregulated in 60µM HOCl treated cells. B) Grp75 (spot no. 477) is shown 
upregulated in 60µM HOCl treated cells. Actin, which is not differentially expressed 
is used as a control. 
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3.5 Three identified spots that are both differentially expressed & oxidized 
upon 60µM HOCl treatment. 
 
From our results, we found three proteins of interest that are both 
differentially regulated and carbonylated. These proteins are Grp75 (Figure 21A), 
solute carrier family 25 member 24, isoform 1 (Figure 21B) and cytochrome c-type 
heme lyase (Figure 21C). These three proteins are all located in the mitochondrion. 
Significance of the changes in expressions and modifications to these proteins will 









































Figure 21A: Spot 477 is upregulated and oxidized in 60µM HOCl treated cells. A 
& B: 3D views of the protein spot in control and treated gels respectively. C: DIGE 
spot image. D: graphical view on the comparison of control versus treated. E: images 
of the western blotting results for control and the treated samples.  
Spot No. : 477 - Upregulated in 60µM HOCl treated only. [In whole cell]
     
* Protein ID: (P38646) Stress-70 protein, mitochondrial precursor (75 
kDa glucose regulated protein ) (GRP 75)(Peptide-binding protein 4) 
(PBP74) (Mortalin) 
 
* Subcellular location: Mitochondrion. 























Figure 21B: Spot 919 is downregulated and oxidized in 60µM HOCl treated cells. 
A & B: 3D views of the protein spot in control and treated gels respectively. C: DIGE 
spot image. D: graphical view on the comparison of control versus treated. E: images 
of the western blotting results for control and the treated samples. 
A. B.
D. C. 
Spot No. : 919 - Downregulated in 60µM HOCl treated only. [In whole 
cell] 
 
* Protein ID: (Q6PJJ9) Solute carrier family 25 member 24, isoform 1 
[Solute carrier family 25 (Mitochondrial carrier\; phosphate carrier), member 24 
/ Small calcium-binding mitochondrial carrier 1 ] 
 
* Subcellular location: Integral membrane protein. Mitochondrial inner 
membrane. 
ІІ. 
Oxidized in 60µM HOCl treated only. [In whole cell and mitochondria] 
919 
31 











Figure 21C: Spot 954u is upregulated and oxidized in 60µM HOCl treated cells. 
A & B: Silver stained views of the protein spot in control and treated gels 
respectively. C: DIGE spot image. D: images of the western blotting results for 
control and the treated samples. 
A. B.
C.
Spot No. : 954u - Upregulated in 60µM HOCl treated only. [In 
mitochondria] 
 
* Protein ID: (P53701) Cytochrome c-type heme lyase. 
 
* Subcellular location: Mitochondrion; mitochondrial inner membrane. 
ІІ. 
Oxidized in 60µM HOCl treated only. [In mitochondria] D. 
954



















3.6 Gene Ontology classifications of the proteins identified 
 
To analyze the differentially expressed and oxidized proteins identified, we used 
an in-house database system (SPLASH) to classify the HOCl regulated proteins according 
to their gene ontology. Figure 22 shows the differentially expressed proteins categorized 
with respect to their (A) subcellular localization and (B) protein cellular functions. Figure 
23 shows categorization of the oxidized proteins.  
With reference to Figure 22, most of the proteins found to be differentially 
expressed are cytoplasmic proteins (37%), followed by mitochondrial and membrane 
proteins (each consisting 22%), some nuclear (7.4%) and ER (3.7%) proteins, with 7.4% 
of unknown cell localization. Of these, majority of proteins function in binding (31.2%), 
metabolism (27.1%) and catalytic activity (22.9%). The rest were proteins that are 
involved in cell death (6.2%), transporter activity (4.2%), anti-oxidant activity (2.1%) and 
structural molecule activity (2.1%). The remaining 4.1% were not classified. 
As for the proteins that were oxidized / carbonylated (Figure 23), most of the 
identified proteins localized mainly in cytoplasm (39.5%) and in the nucleus (24.4%). 
These are followed by mitochondrial (14%), membrane (14%), ER (4.7%), extracellular 
region (1.2%) proteins, and some proteins of unknown cell localization (2.3%). They 
function mainly in binding (32.7%), metabolism (28.8%) and catalytic activity (16.3%). 
Besides proteins that are involved in structural molecule activity (6.5%), cell death (5.2%), 
transporter activity (4.6%), anti-oxidant activity (1.3%), and some of unknown functions 
(1.3%), there is an additional class of proteins oxidized that functions in signal 

























Figure 22: Gene Ontology (GO) classifications of differentially expressed proteins 
identified. The differentially expressed proteins detected using DIGE are classified 





























Figure 23: Gene Ontology (GO) classifications of oxidized / carbonylated proteins 
identified. The differentially expressed proteins detected using western blotting with 
anti-DNP antibodies are classified according to their (A) subcellular location and (B) 
cellular functions. 




3.7 Probable chlorinated proteins 
 
Other than carbonylation, HOCl can also modify proteins via chlorination. 
Chlorinated products of aromatic and related amino acids of proteins, such as chlorinated 
tyrosines (3-chlorotyrosine and 3,5-dichlorotyrosines) can retain chlorine and are stable 
under the acid conditions required to hydrolyze proteins (Winterbourn et al., 2000), they 
are ideal biomarkers for detection of proteins specifically modified by HOCl. 
Since there are no commercially available antibodies for the detection of 3-
chlorotyrosine and 3,5-dichlorotyrosines modifications in HOCl-modified proteins, we 
tried using an indirect method by checking if any of the oxidized proteins are chlorinated 
using mass spectrometry. To detect probable chlorinated proteins, delipidated BSA is 
treated with HOCl and subjected to mass spectrometry to generate its PMF for detection 
of chlorinated peptides (see Figure 24). This is followed by observation of the PMFs 
generated to see if there is any trend in changes to the PMF of a chlorinated protein as 
compared to the normal, unmodified protein. This can subsequently be used as a reference 
to identify any proteins in the treated HepG2 cells that are chlorinated. 
 With this method, one of the oxidized isoforms of hnRNP K (spot 59) was found 
to be possibly chlorinated (see Figure 25). The mass 1917.05 of one of the peptides of this 
protein was found in both control and treated samples, but an additional mass of 1954.10 
corresponding to this peptide was detected in the treated sample but not in the control. 
Mascot search result showed that the protein might be chlorinated at the tyrosine residue 
(residue 380) of peptide 378 – 396 (GSYGDLGGPIITTQVTIPK). And the mass of 
1954.10 that was detected seems to indicate an addition of mass of 37 to the original mass 
of 1917.05. 
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 Another protein found to be possibly chlorinated was one of the oxidized isoforms 
of Lamin A/C protein (spot 98). The peptide mass 1893.88 of this protein was found in 
both control and treated sample, but an additional peptide mass of 1928.87 was found only 
in the treated sample (see Figure 26). Mascot search result showed that the protein might 
be chlorinated at the tyrosine residue (residue 359) of peptide 352 - 366 
(MQQQLDEYQELLDIK). And the mass of 1928.87 that was detected seems to indicate 
an addition of mass of 35 to the original mass of 1893.88. 
 To check if the chlorinated tyrosine residues which are slightly polar, are exposed 
(hydrophilic) or hidden (hydrophobic) within the protein folds of the protein structure, we 
generated an amino acid hydrophilic / hydrophobicity scale plot of hnRNP K and Lamin 
A/C (Figure 27). Results show that both the chlorinated residues are positioned at the 

























Figure 24: Peptide mass fingerprint (PMF) of delipidated BSA – (A) normal & 
(B) HOCl treated. Peptide mass of 1305.75 (blue *) is seen in both normal and 
HOCl treated BSA. Peptide mass of 1343.74 (1305.79 + chlorination 37) (red *) is 






























 Spot No. : 59           
* Protein ID: (P61978) Heterogeneous nuclear ribonucleoprotein K 
(hnRNP K) (Transformation up-regulated nuclear protein) (TUNP). 
 
* Subcellular location: Cytoplasmic / nuclear; nucleoplasm. 
1917.05
1954.10 





1917.05 - 378 - 396 ----- GSYGDLGGPIITTQVTIPK





Figure 25: PMF of hnRNP K showing possible chlorination of the protein. 
MASCOT search results of the peptide show possible chlorination of the peptide at 



























Spot No. : 98           
* Protein ID: (P02545) Lamin A/C (70kDA Lamin). 
 
* Subcellular location: Nuclear lamina, nucleoplasm. 
1893.88 
1928.87 




1893.88 - 352 - 366 ----- MQQQLDEYQELLDIK 




Figure 26: PMF of Lamin A/C showing possible chlorination of the protein. 
MASCOT search results of the peptide show possible chlorination of the peptide at 






















 Figure 27: Amino acid scale representation (Hydrophobicity / hydrophilic 
plot) of hnRNP K and Lamin A/C. A) The chlorinated tyrosine residue (380) 
of hnRNP K is at hydrophilic surface of the protein. B) The chlorinated tyrosine 
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4. DISCUSSION 
 
Extensive evidence for the involvement of HOCl in inflammatory hepatocytes 
and Kupffer cells in human cirrhotic liver (Brown et al., 2001) and murine models of 
endotoxemia (Gujral, Hinson, and Farhood et al., 2004), led us to study the effect of 
HOCl oxidative / chlorinative stress on liver cell lines in vitro. We chose a non-biased 
proteomics approach such as two dimensional difference gel electrophoresis (2D-DIGE), 
and western blotting with antibodies against oxidized/carbonylated proteins, to 
investigate global changes in protein expression of HOCl-treated human hepatoma 
HepG2 cell line. This will enable us to uncover molecular players and decipher 
mechanisms that result in cellular oxidative stress and eventually cell death via 
apoptosis or necrosis in liver cells.  
Permanent cell cultures (cell lines) but not primary cultures were used in our 
experiment due to the following reason. Functionally differentiated primary cultures 
obtained directly from an animal have a limited lifespan as they can only keep their 
differentiated state for a short period. Cell lines which originate from embryos, tumors 
or transformed cells, on the other hand, have an unlimited proliferation capacity and 
elicit similar status and response under long-term permanent culturing conditions.  
 Recent study has established the response of HepG2 cells to HOCl treatment 
whereby the cells undergo mitochondrial dysfunction and apoptosis (Whiteman et al., 
2005). Thus, we decided to use this cell line in our proteomics study to elucidate the 
mechanisms and pathway of HOCl-induced apoptosis and mitochondrial dysfunction. 
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4.1 Biological effect of HOCl treatment on HepG2 cells 
 
A recent study published by Whiteman et al., showed the percentage viability of 
cells exposed to increasing concentrations of HOCl (Figure 28).  
From the data, it can be seen that at 1 minute of HOCl exposure, there was no 
significant effects on cell viability even at high concentrations of HOCl used. In 
contrast, a prolonged 30 minutes exposure resulted in an immediate drop in cell 
viability at low doses of HOCl. This indicates that prolong exposure to HOCl results in 
cytotoxic necrotic cellular damage. 
Between 10-20 minutes of HOCl exposure, cells exhibited gradual loss of 
viability with increasing concentration of HOCl. However, it was noted that high 
concentration of HOCl were required to achieve the same cytotoxic effects at 10 
minutes than at 20 minutes. 
To avoid the extreme cytotoxic effects of HOCl on HepG2 cells and to 
investigate the gradual response of cells to HOCl treatment, we decided to subject the 
HepG2 cells to 30µM and 60µM of HOCl treatment, for duration of 20 minutes in our 
experiments. From Figure 28, it can be seen that cells treated with 30µM of HOCl for 
20 minutes exhibited about 65% cell viability. At 60µM of HOCl, the cells showed 


















With the cell images seen in Figure 5, section 3.1, we can see that after 20 
minutes of 60µM HOCl treatment, cells showed changes in cell morphology. The cells 
changed from their normal satellite nature (Figure 5A) to adopt a rounded morphology, 
detached from its neighbours and the stratum (Figure 5B). In addition, the cells 
exhibited cell shrinkage and typical apoptotic blebbing. These suggested that HepG2 
cells subjected to HOCl – mediated oxidative stress, underwent changes in structural 
integrity, with loss of cell viability via apoptosis.  
Evidence of cell death via apoptosis by HOCl-mediated oxidative stress is 
shown by the presence of classical hallmarks of apoptosis, including annexin V labeling, 
caspase activation, chromatin condensation, and cell body shrinkage (Whiteman et al., 
2005). Demonstration of mitochondrial swelling and collapse of the mitochondrial 
membrane potential with the concomitant release of cytochrome c in HOCl treated 
30 60
Figure 28: Effect of HOCl on HepG2 cell viability. Graph shows cell viability 
assay using MTT, with increasing concentration of HOCl exposure at four different 
time points (Whiteman et al., 2005).  
Discussion  118 
HepG2 cells also show that HOCl induced mitochondrial dysfunction and apoptosis, 
was dependent on the induction of the mitochondrial permeability transition (MPT). 
 
4.2 Cells response to increasing concentration of HOCl treatment 
4.2.1 Differentially expressed proteins 
Cells when treated with 30µM of HOCl showed no major differences in protein 
profile as compared to the normal, untreated cells. This can be seen in Figure 6A, where 
the DIGE image of the control versus 30µM HOCl showed no detectable differentially 
expressed protein except for two significant protein spots that were found upregulated. 
With higher dosage of HOCl treatment at 60µM HOCl (Figure 6B), it can be seen that 
there was a significant increase in the number of proteins affected by the HOCl – 
mediated oxidative stress.  17 more differentially expressed proteins were significantly 
detected, with the majority being downregulated (Figure 7).  
With reference to section 3.6 (Figure 22), most of the proteins found to be 
differentially expressed were cytoplasmic proteins, followed by mitochondrial and 
membrane proteins, and some nuclear and ER proteins. The majority of these proteins 
function in binding, metabolism and catalytic activities, while the rest were involved in 
cell death, transporter activity, antioxidant activity and structural molecule activity. 
We shall discuss some of these candidates in relation to their roles in HOCl-
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4.2.2 Oxidized proteins via carbonylation 
 
Proteins that are involved in signal transduction processes can undergo specific 
post–translational chemical modifications, resulting in either gain or lost of a chemical 
entity. Such changes alter their functions or structures to either activate or inactivate 
them, and can lead to cell survival or cellular death. In cells subjected to oxidative stress, 
the proteins can react with the oxidant and its intermediates to form post-translational 
chemical modifications such as carbonylation (see section 1.5.4). This is an irreversible 
oxidative modification that can be introduced into proteins at different residues by 
various oxidative mechanisms. Thus detection of carbonylation would be ideal for 
identifying proteins that are altered by the oxidative stress induced by HOCl treatment 
on cells. 
In the oxidation / carbonylation profile illustrated in Figure 14, we can see 
significant oxidative-stress induced changes in the 30µM HOCl treated cells. 10 spots 
which exhibited basal oxidation in untreated cells underwent increased oxidation. More 
significantly, 23 spots were detected to undergo oxidation only upon HOCl treatment, 
but were not oxidized in untreated cells. With 60µM of HOCl treatment, we can see that 
the cells respond more drastically to this concentration of HOCl treatment, with a total 
of 80 more spots seen oxidized (7 of increasing oxidation and 73 spots expressed 
oxidation only in the treated). Therefore, we can conclude that HOCl-mediated HepG2 
cells dysfunction results in greater changes to the post-translational oxidation status of 
proteins rather than the differential regulation of their expression levels. While the 
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expression levels of majority of the proteins remained unchanged, the alteration in their 
oxidation status could confer a new function or activity to the protein.  
With reference to section 3.6 (Figure 23), most of the proteins found to be 
oxidized were mainly cytoplasmic and nuclear proteins, followed by mitochondrial, 
membrane, ER, and extracellular region proteins, and some proteins of unknown cell 
localization. They function mainly in binding, metabolism and catalytic activities. 
Besides proteins that are involved in structural molecule activity, cell death, transporter 
activity, antioxidant activity, and some of unknown functions, there was an additional 
category of oxidized proteins that function in signal transduction. 
 
4.3 The nucleus as a target of HOCl-mediated oxidative stress 
 
HOCl was found to affect several proteins in the nucleus, such as those that 
function in regulating DNA replication, cell proliferations, transcription and structural 
integrity of the organelle.  Examples are nuclear protein Hcc-1, RuvB-like 1, protein 
DJ-1 and DNA replication licensing factor MCM7. These proteins are involved in 
transcription and control of cell growth. Additional candidates which we found 
carbonylated with HOCl treatment are probable ATP-dependent helicase DDX48, 
nucleophosmin and PRP19/PSO4 homolog which are involved in processing of pre-
ribosomal RNA, assembly and/or transport of ribosome, and DNA repair.  A third class 
of nuclear proteins included lamin A/C, lamin B1 and cofilin which are involved in 
maintaining the framework of the nuclear lamina and intranucleus. Most of these 
proteins were oxidized / carbonylated upon HOCl treatment. 2 of them, cofilin and 
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DnaJ homolog, both functioning in cell cycle progression restoration, were 
differentially expressed. 
Lamin A/C (or progerin) and lamin B1 are components of the nuclear lamina, 
which forms a fibrous layer on the nucleoplasmic side of the inner nuclear membrane. 
They function in providing a framework for the nuclear envelope and may also interact 
with chromatin. Modification of these proteins via carbonylation might result in loss of 
function of these proteins, thus affecting the proper nuclear components and chromatin 
arrangements. With downregulation of cofilin, structural integrity of the nucleus might 
also be disintegrated. This is consistent with the observation of changes in cell 
morphology (rounding and blebbing) with HOCl treatment. In addition, Lamin A/C is 
also found to be possibly chlorinated (3-chlorotyrosine) at one of its tyrosine residues 
(see Figure 26). 
 Hetereogeneous nuclear ribonucleoproteins (hnRNPs) are among the most 
abundant proteins in the eukaryotic nucleus. These proteins play important roles in 
transcription, processing of pre-mRNA, alternative splicing and nucleocytoplasmic 
shuttling (Krecic et al., 1999; Michael, 2000; Shyu et al., 2000). Many hnRNPs are 
characterized at the molecular level and are classified into different types of hnRNPs 
according to their motifs.  
Involvement of hnRNPs in apoptosis had been demonstrated for some of the 
hnRNPs such as A1, A2/B1 and C1/C2 (Thiede et al., 2002). Some of these hnRNPs 
were found to be oxidized in our study upon HOCl treatment. These include hnRNP-E1, 
a nucleic acid binding protein; hnRNP L, H and F which provide the substrate for the 
processing events that pre-mRNAs undergo before becoming functional, translatable 
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mRNAs in the cytoplasm; hnRNP C1/C2 which may play a role in ribonucleosome 
assembly by neutralizing basic proteins such as A and B core hnRNP; and hnRNP K 
which is one of the major pre-mRNA-binding proteins that binds tenaciously to poly(C) 
sequences.  
hnRNP K is found likely to play a role in the nuclear metabolism of hnRNAs, 
particularly for pre-mRNAs that contain cytidine-rich sequences, and can also bind 
poly(C) single-stranded DNA. hnRNP K was also found in our study to be possibly 
post-translationally modified at one of its tyrosine residue via chlorination (3-
chlorotyrosine). See Figure 25. Therefore, modifications to these hnRNPs might cause 
malfunctioning of these proteins in transcription and processing of pre-mRNAs, 




4.4 HOCl-mediated stress results in Mitochondrial dysfunction  
 
The mitochondrion is a vital organelle responsible for providing cellular energy 
through the tricarboxylic (TCA) cycle linked with oxidative phosphorylation, resulting 
in the generation of a chemical potential across the membrane that drives ATP synthesis, 
and providing the energy needed for the various biochemical processes in the cell. It is 
also a crucial player in the apoptosis cascade. Although mitochondria have their own 
genome (mtDNA), most of the proteins that reside in mitochondria are nuclear gene 
products, and so mitochondrial biogenesis requires the coordinated gene expression of 
both nuclear and mitochondrial genomes. The precursor proteins of mitochondrial 
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proteins that are produced in the nucleus are then required to be imported into the 
mitochondrion, and ensured to be properly folded. 
From our results, multiple mitochondrial proteins were found to be 
downregulated and carbonylated by HOCl-mediated oxidative stress, which might result 
in mitochondrial dysfunction, leading to apoptosis. 
In our study, precursor protein import into the mitochondria was affected in the 
HepG2 cells exposed to HOCl. Three of the essential proteins required in the process 
were found to be carbonylated and/or differentially expressed; they are cytosolic hsp70 
chaperon protein, chaperonine hsp60 and mitochondrial-processing peptidase (MPP). 
During normal function, the precursor protein with its N-terminal matrix-
targeting sequence that is synthesized in the cytosol, first binds to a cytosolic hsp70 
chaperone protein which uses energy released by ATP hydrolysis to keep the precursors 
unfolded. The precursor-chaperone complex then binds to one or more receptors on the 
outer mitochondria membrane near a site of contact with the inner membrane, and the 
protein is then translocated across the outer and inner membranes through an import 
channel. Upon entering, the newly imported protein then binds to the matrix chaperone 
hsp70 which uses energy from ATP hydrolysis to import the protein into the matrix, and 
at the same time, prevent aggregation and premature folding of the protein. The protein 
is then released from matrix hsp70 and binds to chaperonine hsp60 which facilitates the 
correct folding of imported proteins into their final active form with energy provided by 
the hydrolysis of ATP. The uptaking targeting sequence is then removed by a matrix 
protease such as mitochondrial-processing peptidase (MPP), which catalyzes the 
specific cleavage of the diverse presequence peptides from hundreds of the nuclear-
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encoded mitochondrial precursor proteins that are synthesized in the cytosol and 
imported into the mitochondrion. 
Cytosolic hsp70 chaperone protein, chaperonine hsp60 and MPP were 
carbonylated in our study. These alterations possibly leads to the impairment of the 
import of precursor proteins into the mitochondrial, and proper folding and specific 
cleavage of the uptaking targeting sequence might thus be severely impaired. As such, it 
would lead to dysfunction in mitochondrial assembly and activity as evident by the 
downregulation of various mitochondrial proteins such as succinyl-CoA:3-ketoacid-
coenzyme A transferase 1, mitochondrial precursor; agmatinase, mitochondrial 
precursor; and solute carrier family 25 member 24 (isoform 1). 
Mitofilin, a transmembrane protein of the inner mitochondrial membrane and 
the voltage dependent anion selective channel protein 2 (VDAC 2) on the outer 
mitochondrial membrane were found to be oxidized / carbonylated. This might provide 
first evidence that HOCl and its intermediates actually penetrate to the mitochondrial 
matrix in whole cells.  
It was also shown from our results that cytochrome c heme lyase (also known as 
cytochrome c synthethase), which functions in addition of heme to apocytochrome c 
(holocytochrome c) so that it can confer a conformational change to the latter, to 
prevent its diffusion through the outer membrane and lock it into the intermembrane 
space, was carbonylated and upregulated in the HOCl treated cells.  
Carbonylation of cytochrome c heme lyase might result in loss of function to the 
protein, thereby causing cytochrome c to diffuse out of mitochondrial into the cytosol. 
Upregulation of this protein might be an attempt as a survival mechanism. A recent 
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study on the HOCl-mediated dysfunction and apoptosis in HepG2 cells (Whiteman et 
al., 2005) showed HOCl induced release of cytochrome c into the cytosol. This 
suggested that the release of cytochrome c might be contributed by the mechanism 
mentioned above. 
Grp75 / Mortalin, reported to bind to several proteins, including NADH 
dehydrogenase, Tim-44, Tim-23, hsp60 and p53, has been suggested to be involved in 
cell survival, control of proliferation and in stress response (Choi et al., 2004). A study 
on yeast cells illustrated that functional inactivation of mitochondrial mortalin by 
oxidation resulted in mitochondrial aggregation, defects in energy and calcium supply, 
and eventually leads to cell death (Kawai et al., 2001). In our results, Grp75 is found to 
be slightly upregulated but carbonylated in HepG2 cells upon HOCl treatment. 
Oxidation of Grp75 might alter its function such that its role in maintaining cell survival 
during oxidative insult might be affected.  
 
 
4.5 Proteins with different functional capabilities in the cells were affected 
 
4.5.1 Proteins that function in binding and catalytic activity 
 
From our results, it was shown that several proteins with binding and catalytic 
activities involved in cell proliferation and metabolism, playing a role in DNA 
replication and transcription were oxidized. These proteins include ruvB-like 1 (49-kDa 
TATA box-binding protein-interacting protein), aldose reductase (aldehyde reductase), 
and ribonucleoside-diphosphate reductase large subunit (M1 subunit).  
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 RuvB-like 1 protein has single-stranded DNA-stimulated ATPase and ATP-
dependent DNA helicase (3' to 5') activity which suggests a role for it in nuclear 
processes such as recombination and transcription. In addition, it can stimulate gene 
activation mediated by beta-catenin and T-cell factor (TCF) complex. Ribonucleoside-
diphosphate reductase M1 subunit functions in providing the precursors necessary for 
DNA synthesis by converting 2'-deoxyribonucleoside diphosphate to ribonucleoside 
diphosphate, and is involved in the first step of DNA replication pathway. 
Carbonylation of these proteins possibly results in loss of functions of these proteins, 
thereby leading to defects in cell proliferation. 
Another protein spliced isoform 1 of anamorsin, which is a cytokine-induced 
apoptosis inhibitor required during hematopoiesis to mediate anti-apoptotic effects of 
various cytokines, was found to be oxidized as well. Oxidation of this protein might 
affect its anti-apoptotic functions. With the cell proliferation processes affected as well, 
cells under intense oxidative stress with impairment of their anti-oxidant activities 
might head towards cell death via apoptosis or necrosis. 
 
4.5.2 Proteins that function in metabolism 
 
Glyceraldehydes-3-phosphate dehydrogenase (GAPDH) which functions in the 
glycolysis/gluconeogenesis pathway had found to be oxidized and inhibited by HOCl-
mediated oxidative stress in cells (Abernathy et al., 1995; Dallegri et al., 1988; 
Schraufstätter et al., 1990). In our study, we found GAPDH to be downregulated in 
60µM HOCl-treated HepG2 cells (Tables 4 and 5) as well. Fructose-bisphosphate 
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aldolase C which functions in carbohydrate degradation and step 4 in glycolysis; 
converting D-glyceraldehyde 3- phosphate and glycerone phosphate from D-glucose, 
was oxidized as well. 
Creatine kinase B, which catalyzes the transfer of phosphate between ATP and 
various phosphogens (e.g. creatine phosphate) was found to be increasingly oxidized 
upon 60µM HOCl treatment. This protein had been found in previous studies to be 
moderately susceptible to inactivation by sublethal concentrations of HOCl (Pullar et al., 
1999). The oxidation of this protein could be one mechanism contributing to its 
inactivation. 
 Two catalytic enzymes involved in the liver methionine cycle were found to be 
oxidized upon HOCl treatment. The first enzyme S-adenosyl methionine synthetase 
gamma form (also known as methionine adenosyltransferase, MAT), is involved in 
catalyzing the formation of S-adenosylmethionine (SAM or AdoMet) from methionine 
in the presence of ATP. The second enzyme adenosylhomocysteinase (also known as S-
adenosyl-L-homocysteine hydrolase or AdoHcyase), catalyzes the conversion of S-
adenosylhomocysteine (SAH) to homocysteine. It functions as a competitive inhibitor 
of S- adenosyl-L-methionine-dependent methyl transferase reactions; and therefore may 
play a key role in the control of methylations via regulation of the intracellular 
adenosylhomocysteine level. With the carbonylation of these protein enzymes, there 
might be a loss of function of these proteins. As a result, SAH might accumulate and 
AdoMet level reduced, thus affecting the methionine and methylation cycle. Recent 
work has shown that deficiency of AdoMet impaired mitochondrial function and 
generated oxidative stress in the liver (Santamaria et al., 2003). 
Discussion  128 
 Besides the methionine cycle, enzymes in other metabolic pathways that are 
specific in liver are affected as well. Biliverdin reductase A precursor which functions 
in heme metabolism pathway specifically in liver, was found downregulated in HOCl 
treated HepG2 cells. This protein functions in reducing the gamma-methene bridge of 
the open tetrapyrrole, biliverdin IX alpha, to bilirubin with the concomitant oxidation of 
a NADH or NADPH cofactor. Agmatinase or agmatine ureohydrolase, a mitochondrial 
precursor which is involved in the putrescine biosynthesis pathway, and catalyzes the 
formation of putrescine and urea from agmatine, was also found to be downregulated. 
As putrescine biosysnthesis is found to influence cell growth, downregulation of this 
protein might affect the liver cell proliferation, as evident by the MTT assay results. 
 Enzymes that are involved in cofactor biosynthesis such as dihydrofolate 
reductase (DHFR) and ribonucleoside-diphosphate reductase were also found to be 
affected in HOCl-mediated oxidative stress. DHFR which catalyzes tetrahydrofolate 
biosynthesis from 2–amino–4–hydroxyl–6–hydroxymethyl-7,8-dihydropteridine 
diphosphate and 4-aminobenzoate in step 3 (final step) of the cofactor biosynthesis 
pathway, was found to be downregulated. As the reaction catalyzed by this enzyme 
represents an essential step for de novo glycine and purine synthesis, DNA precursor 
synthesis, and for the conversion of dUMP to dTMP, downregulation of this protein 
might affect cell replication and function negatively. As mentioned above (section 
4.3.1), ribonucleoside-diphosphate reductase M1 subunit which also provides 
precursors necessary for DNA synthesis by catalyzing 2'-deoxyribonucleoside 
diphosphate to ribonucleoside diphosphate is also oxidized. Therefore possible 
inactivation of this protein by oxidation / carbonylation might affect the synthesis of 
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these precursors necessary for DNA synthesis and might eventually result in 
impairment of cell proliferation. 
 
4.5.3 Proteins involved in antioxidant activity 
A variety of proteins function as scavengers of superoxide and hydrogen 
peroxide. They include SOD, catalase, glutathione peroxidase, thioredoxin, and the 
peroxiredoxin family of proteins, which are involved in redox regulation of the cell. 
When cells undergo oxidative stress, the thioredoxin and peroxiredoxin family of 
proteins in particular could be induced to protect the cells from oxidative damage.  In 
our study, peroxiredoxin 3 (also known as thioredoxin-dependent peroxide reductase) 
which functions in protecting radical-sensitive enzymes from oxidative damage by a 
radical-generating system, was found to be upregulated when the cells were subjected to 
HOCl-mediated oxidative stress. 
Peroxiredoxins have one or two conserved cysteine residues in their sequence 
(1-Cys and 2-Cys forms) which upon reaction with peroxide, can be oxidized by the 
peroxide to either one of two forms: cysteine sulfenic acid in 1-Cys peroxiredoxins 
(Choi et al., 1998) or disulfide in the 2-Cys peroxiredoxins (Chae et al., 1994). To 
complete the enzymatic catalytic cycle, the oxidized peroxiredoxins are reduced back to 
their active thiol form, for example by the thioredoxin-thioredoxin reductase system for 
2-Cys peroxiredoxins (Chae et al., 1994; Kwon et al., 1994; Rabilloud et al., 2002). 
There are generally two classical cytosolic 2-Cys peroxiredoxins, namely peroxiredoxin 
1 and peroxiredoxin 2. Another isoform named peroxiredoxin 3 resides in mitochondria.  
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Recent studies have also found that cells in response to oxidative stress, induced 
expression of peroxiredoxins variants with phosphorylation and other uncharacterized 
PTMs (Mitsumoto and Nakagawa et al., 2001; Mitsumoto and Takanezawa et al., 2001). 
This ties in with our findings of oxidized / carbonylated forms of peroxiredoxin 6 which 
functions in reducing H2O2, short chain organic fatty acid, and phospholipids 
hydroperoxides. 
Besides peroxiredoxin 6, thioredoxin reductase 1 and thioredoxin-like protein 2 
were found to be modified by carbonylation as well. Thioredoxin reductase 1 is a 
cytoplasmic precursor that functions in reducing peroxiredoxins to their active forms 
via catalytic conversion of NADP to NADPH. Thioredoxin-like protein 2 (also known 
as PKC-interacting cousin of thioredoxin) is a cytoplasmic protein which resides under 
the plasma membrane, and plays a role in regulating the thioredoxin system. The 
carbonylation of these proteins indicates that the thioredoxin ‘repair’ system might thus 
be affected, preventing the peroxiredoxins to be converted back to their active forms to 
overcome the oxidative stress imparted on the cells. As such, the redox regulation of the 
cells which serves as a protective mechanism against oxidative stress could be impaired. 
 
4.5.4 Proteins involved in cell proliferation /cell death /signal transduction 
 
A number of nuclear proteins that directly play a role in promoting DNA 
replication and cell proliferation are found to be affected in our study. HCC-1 protein 
which is a proliferation-associated cytokine-inducible nuclear protein, and may have 
nucleic acid binding capability that participate in important transcriptional or 
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translational control of cell growth, metabolism and carcinogenesis, was found to be 
oxidized in our study. DNA replication licensing factor MCM7 which was found to be 
carbonylated acts as a factor that allows the DNA to undergo a single round of 
replication per cell cycle and is required for proper regulation of DNA replication and 
cell proliferation was found carbonylated as well. Possible inactivation of these proteins 
via carbonylation might thus contribute to decreased cell proliferation as evident in the 
MTT assay. 
DnaJ protein that acts as co-chaperone of heat shock cognate 70, and functions 
in cell cycle progression restoration was found to be differentially expressed and 
possibly modified (not characterized) upon HOCl treatment. There were two isoforms 
of the protein detected in our study with DIGE. One isoform which was found present 
in normal cells, was found to be downregulated in HOCl treated cells, and the other 
isoform (more acidic) was found present only upon 60µM HOCl treatment. Therefore, 
modifications of these proteins might result in loss of function of these cell proliferation 
promoting factors, thereby pushing the cells towards cell death. 
Besides proteins that function in promoting cell proliferation, proteins that 
function in protecting the cells against oxidative stress and cell death were also affected. 
One of these proteins is DJ-1 protein, an oncogene protein. 
DJ-1 protein has two isoforms, one of pI 5.8 and the other of pI 6.2. This protein 
functions as a positive regulator of androgen receptor-dependent transcription, and may 
act as redox-sensitive chaperone and sensor for oxidative stress whereby it aids in 
refolding misfolded proteins induced by oxidative and other cell-stress conditions. DJ-1 
might also influence the expression of genes for stress response at transcriptional and 
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post-transcriptional levels by interacting with the protein inhibitor of activated STAT, 
other nuclear cofactors and with cytosolic RNA-binding protein complexes. Human 
cells exposed to sublethal levels of oxidative stress, such as paraquat which generates 
reactive oxygen species (ROS) within cells, demonstrated an increase of oxidized forms 
of DJ-1 in response to sublethal levels of the oxidant (Mitsumoto and Nakagawa et al., 
2001). Another study on DJ-1 also showed a linkage of its dysfunction to 
neurodegeneration (neuronal cell death) in alzheimer’s disease (Bonifati et al., 2004). In 
our study, we found that the two isoforms of this protein (one at ~ pH 5.8 and another at 
~ pH6.2) were found to be increasingly carbonylated in HepG2 cells when exposed to 
HOCl-mediated oxidative stress. Together with the published evidences, this might 
suggest loss of function of this protein especially with both isoforms carbonylated.  
Phosphatidylethanolamine-binding protein (PEBP) is a protein that interacts 
with Raf-1 in the MAPK signalling pathway. It inhibits the phosphorylation and 
activation of MEK by Raf-1 and is also known as RKIP (Raf kinase inhibitor protein) 
(Yeung et al., 1999). MAPK signalling pathway regulates various cellular activities, 
such as gene expression, mitosis, differentiation, and cell survival/apoptosis. PEBP 
binds ATP, opioids and phosphatidylethanolamine, and has lower affinity for 
phosphatidylinositol and phosphatidylcholine. Upregulation of this protein might result 
in inhibition of the phosphorylation of MEK by Raf, thereby inhibiting the MAPK 
signalling pathway.  
Programmed cell death 6-interacting protein (PDCD6-interacting protein) which 
might play a role regulation of both apoptosis and cell proliferation is oxidized as well. 
Inactivation of this protein by carbonylation might also contribute to cell death. 
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4.5.5 Proteins with protein transporter activity 
 
Several proteins that are involved in protein transporter activities were found to 
be either oxidized or differentially expressed. Three of these proteins are involved in 
mitochondrial functions.  
Probable mitochondrial import receptor subunit TOM40 homolog which is 
essential for the import of protein precursors into the mitochondria was found to be 
increasingly oxidized upon HOCl treatment. Oxidation / carbonylation of this protein 
might negatively affect its function; thereby inhibit the import of protein precursors of 
mitochondrial proteins into the mitochondria, causing mitochondrial dysfunction. 
A calcium-dependent mitochondrial aspartate and glutamate carrier, known as 
the solute carrier family 25, member 24 protein, which may play a role in the urea cycle, 
was both downregulated and oxidized. This suggests inactivation of the protein which 
might affect the import of aspartate and glutamate essential for the urea cycle, giving 
rise to dysfunction of the mitochondrial urea cycle.  
Voltage-dependent anion-selective channel protein 2 (VDAC-2), which resides 
in the outer mitochondrial membrane was found in our study to be oxidized by HOCl or 
its intermediates upon 60µM HOCl treatment. This protein can form a channel which 
allows diffusion of small hydrophilic molecules. VDAC is also found to come together 
with proteins like the adenine nucleotide translocase (ANT), the mitochondrial inner 
membrane protein transporter (Tim), the protein transporter at the outer membrane 
(Tom), and cyclophilin-D (Fiskum, 2001) to form the mitochondrial permeability 
transition (MPT) pore. MPT pore when opened can cause an increase in the 
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permeability of the mitochondrial membrane to molecules weighing less than 1500 
Daltons. A recent study that investigated the effects of HOCl on mitochondrial function 
in HepG2 cells, found that HOCl-induced apoptosis was dependent on the induction of 
the MPT pore (Whiteman et al., 2005). Oxidation of VDAC 2 might play a role in this 
induction, and might either positively or negative affect the functionality of the protein. 
It might also be possible that HOCl or its intermediates could enter the opened MPT 
pore and react with VDAC 2 along its passage causing oxidation of the protein. 
Proteins involved in forming membrane fusion or vesicles; and/or exocytosis, 
such as synaptic vesicle membrane protein VAT-1 homolog and Annexin A7 (also 
known as synexin), were also found to be upregulated and oxidized respectively.  
 
4.5.6 Proteins that function in structural molecule activity 
 
Several isoforms of actin, which are highly conserved proteins that are involved 
in various types of cell motility, and are ubiquitously expressed in all eukaryotic cells, 
were found to be increasingly carbonylated in our study. F-actin capping protein alpha-
2 subunit which binds in a Ca2+-independent manner to the fast growing ends of actin 
filaments (barbed end), and thereby blocking the exchange of subunits at these ends, 
was found carbonylated as well.  
Carbonylation of actin was found evident in several other tissues exposed to 
oxidative stress in recent studies. A significant elevation of actin carbonyl content was 
discovered in neurons of brain affected by alzheimer’s disease (Aksenov et al., 2001), 
as well as post-ischemic isolated rat hearts (Powell et al., 2001). Actin carbonylation 
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has also been determined in HOCl exposed human intestinal cell line which indicated F-
actin and G-actin oxidation (Banan et al., 2000). A study of oxidative effects induced 
by HOCl on purified actin showed that HOCl caused a rapid increasing yield of 
carbonyl group, with some Cys and Met residues oxidized, and also induced progressive 
disruption of actin filaments and inhibition of F-actin formation (Dalle-Donne et al., 
2001).  Therefore, increase in actin carbonyl content in cells exposed to oxidative stress 
would indicate severe oxidative modifications leading to extreme functional 
impairments. 
A non-muscle isoform of cofilin, cofilin-1, which also functions in actin 
formation by controlling reversibly actin polymerization and depolymerization in a pH-
sensitive manner was found downregulated when exposed to HOCl-mediated oxidative 
stress. This protein has the ability to bind G- and F-actin in a 1:1 ratio of cofilin to actin 
and is the major component of intranuclear and cytoplasmic actin rods. Downregulation 
of this protein contributes further to the impairment of actin formation. 
Other structural proteins that play a role in actin precessing like T-plastin and T-
complex protein 1 – beta subunit, were found to be carbonylated in HOCl oxidative 
stressed HepG2 cells too. The former is an actin-bundling protein found in fibroblast 
filopodia, while the latter is a molecular chaperone that assists the folding of proteins 
such as actin and tubulin upon ATP hydrolysis.  
Alpha and beta tubulins, the major constituents of microtubules; vimentin, a 
class-III intermediate filaments found in various non-epithelial cells, especially 
mesenchymal cells; moesin, a protein involved in connections of major cytoskeletal 
structures to the plasma membrane; and keratin type I and II of keratin (which is a 
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heterotetramer of two type I and two type II keratins cytoskeletal and microfibrillar 
keratin), were all found oxidized / carbonylated upon HOCl treatment.  
Therefore it appears that the cytoskeletal structural proteins of HepG2 cells were 
modified severely by HOCl treatment. This might impair their functions, leading to 
changes in morphology and cell integrity of the treated HepG2 cells as described and 
shown in Figure 5 in chapter 3. 
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5. CONCLUSION & RECOMMENDATIONS 
 
In our study on HOCl-mediated oxidative stress on HepG2 cells, we 
successfully identified proteins which were regulated by HOCl and its intermediates 
using 2-D DIGE and western blotting analysis, coupled with mass spectrometry. These 
differentially regulated and carbonylated protein candidates have important roles in 
regulating various aspects of cellular function, such as proteins involved in metabolism, 
signal transduction, cell growth and antioxidant activities. Downregulation and 
modification of important proteins such as GAPDH, DJ-1 and the peroxiredoxins, 
resulted in the loss of protein functions essential for the normal cellular processes, 
resulting in cellular dysfunction and consequently of cell death.  
With the carbonylation of mitochondrial membrane proteins such as VDAC 
which resides on the outer membrane, and mitofilin on the inner mitochondrial 
membrane; together with carbonylation of several mitochondrial matrix proteins, we 
provided first evidence of possible penetration of HOCl and its intermediates into the 
mitochondrial matrix. Thus, we can postulate that mitochondrial might be one of the 
direct targets of HOCl-mediated oxidative stress. To prove this hypothesis, further 
studies can be done whereby isolated mitochondria can be treated directly with HOCl to 
elucidate its response.  
Although we have shown possible chlorination of some of the proteins by 
comparing its PMFs and data from the mascot search results using mass spectrometry, 
further validation has to be done whereby the peptides that are found to be possibly 
chlorinated should be sequenced using nano LC-ESI MS/MS. If we are able to prove 
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chlorination of this protein on the tyrosine residue (3-chlorotyrosines and 3,5-
dichlorotyrosines), we can then see if there are any consensus sequences required for 
chlorination. As such, we would then be able to postulate which are the proteins 
susceptible to HOCl-mediated chlorination.  
To further validate the effects of carbonylation or chlorination of some of the 
proteins and their role in regulations of the cellular functions of the cells during HOCl-
induced oxidative stress, additional functional or enzymatic studies on these proteins 
can be carried out. Examples are knockdown studies on selected proteins to show if 
inactivation of these candidate proteins can elicit the same inhibitory response to the 
cells. 
Some of the protein spots in the 2DE gels were found to consist of mixture of 
proteins instead of only one protein ID. To overcome this problem, we can run our 
sample using IEF strips with narrows pI ranges such as single pI range or 2-3 pI ranges 
strips. This method can also help to separate the different isoforms of a protein with 
differing pI but same molecular weight, and can also allow more proteins to be 
separated and visualized on the 2DE gels.  
2DE gel analysis has certain limitations in the separation and detection of 
proteins of hydrophobic nature and of low-abundance, such as membrane and 
mitochondrial proteins. By complementing sub-cellular protein studies to studies on 
whole cell level, we managed to identify and detect more of these proteins. Other non 
gel-based methods such as methods based 2D- Liquid Chromatography (2DLC) and 
Multi-dimensional Liquid Chromatography (MDLC), which are more useful in 
detecting proteins of low molecular weights and hydrophobic nature can also be used to 
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complement 2DE gels. This will help us to work towards a comprehensive 
understanding of molecular targets of HOCl-response in liver inflammation. Examples 
are the Isotope-coded affinity tagging (ICATTM) method (Gygi et al., 2002) and isotope 
tagging for relative and absolute protein quantitation (iTRAQTM) technology (Ross et 
al., 2004) that enables proteome-wide measurement of protein relative abundances. 
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Formula for Polyacrylamide Gels (12%T Separating) – per gel. 
 
Stock Conc.              Final Conc.       Separating (37.5ml)  
40% Bis/Acryl (37.5:1)                -       11.25 ml 
1.5M Tris-HCl pH 8.8  0.375M      9.375 ml 
10% SDS     0.1%          375 µl 
10% APS        0.1%          375 µl 
Temed        0.05%       18.75 µl 






Formula for Polyacrylamide Gels  (12%T Separating, 4%T Stacking) – per gel. 
 
Stock Conc.              Final Conc.      Separating (10ml) Stacking (5ml) 
40% Bis/Acryl (37.5:1)                -       3.0 ml         500 µl 
1.5M Tris-HCl pH 8.8  0.375M      2.5 ml   - 
1.0M Tris-Hcl pH 6.8  0.126M                 -          630 µl 
10% SDS     0.1%       100 µl           50 µl 
10% APS        0.1%       100 µl                   50 µl 
Temed          0.1%         10 µl             5 µl 
Milli-Q Water                 -       4.3 ml                 3.77 ml 
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